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In the central nervous system, remyelination requires the proliferation and migration of 
oligodendrocyte progenitor cells (OPCs) to the lesions, and the differentiation of OPCs 
into oligodendrocytes that remyelinate the axons. Microglia / macrophages remove 
damaged myelin from the lesions, mediate inflammation, and secrete cytokines and 
growth factors that regulate OPC responses for remyelination. In the mice deficient of 
MyD88 adaptor for inflammatory signaling, the recruitment of OPCs and remyelination 
were impaired after lysolecithin-induced focal demyelination. The lack of MyD88 signaling 
and defective phagosome maturation may impair the clearance of internalized myelin 
debris and the activation of microglia to support remyelination. Transcriptomic and 
proteomic analyses of demyelinated lesions and cultured microglia identified candidate 
molecules and pathways relevant to remyelination. Lysolecithin or autoimmune-mediated 
demyelination models in organotypic hippocampal slice culture provide ex vivo methods 
for understanding the mechanisms of demyelination and remyelination, and for evaluating 
the effects of candidate molecules on OPC proliferation, differentiation and myelination. In 
addition, MyD88 signaling is necessary for the recruitment of OPCs during remyelination 




The central nervous system (CNS) is composed of a diverse set of cell types, including 
neurons, glia (astrocytes, oligodendrocytes and microglia) and vascular cells (endothelial 
cells, pericytes and vascular smooth muscle cells) (Zeisel et al., 2015; Zhang et al., 2014). 
Different cell types interact with each other during neural development and for normal 
functions of the nervous system. While neurons, astrocytes and oligodendrocytes 
originate from precursor cells derived from neuroectoderm (Allen and Barres, 2009), 
microglia are immune cells derived from progenitor cells that entered the nervous system 
during embryonic development (Ginhoux and Garel, 2018; Ginhoux et al., 2010). Microglia 
have versatile functions during development, including the regulation of neurogenesis, 
synaptic pruning, the refinement of synapses, and oligodendrocyte development. 
Microglia monitor the CNS to detect pathogens and clear damaged structures and dead 
cells, both of which use their phagocytosis machinery. These resident immune cells also 
mediate inflammation in the CNS. Under physiological conditions, adult microglia display 
ramified morphology with many processes, and each cell is located in its own territory; 
whereas activated microglia have enlarged cell body and shorter processes, and 
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sometimes exhibit amoeboid morphology (Hammond et al., 2018; Hanisch and 
Kettenmann, 2007; Ransohoff and Perry, 2009). The general microglial markers such as 
IBA1 and CX3CR1 could not distinguish microglia from macrophages until recent studies 
identified specific markers that are only expressed by microglia such as SALL1 (Buttgereit 
et al., 2016; Gosselin et al., 2017) and TMEM119 (Bennett et al., 2016; Satoh et al., 
2016). In the case of demyelination, both microglia and monocyte-derived macrophages 
are found in demyelinated lesions (Davies and Miron, 2018; Franklin and Ffrench-
Constant, 2017). Nonetheless, the functions of microglia in remyelination were the main 
focus of this study. 
 
Myelin is the multilayered membrane wrapped around axons in the vertebrate nervous 
system. Myelin sheaths are formed by oligodendrocytes in the CNS, and by Schwann 
cells in the peripheral nervous system (PNS). Myelin insulates axons and restricts Na+ 
channels to the nodes of Ranvier, which results in the saltatory conduction of action 
potentials between the nodes. This allows fast nerve conduction in relatively thin axons 
and saves energy. Oligodendrocytes also provide trophic and metabolic support for axons 
through myelin, which helps to maintain axonal integrity and health (Bercury and Macklin, 
2015; Kremer et al., 2016). Myelination in humans is most active in the first year of life and 
continues during young adulthood, especially in the prefrontal cortex (Sowell et al., 1999; 
Sowell et al., 2001). In mice, myelination starts at birth in the spinal cord, peaks between 
postnatal day (P) 10 and 20, and becomes almost completed by P60 in most brain 
regions. During development, oligodendrocyte progenitor cells (OPCs) proliferate and 
migrate out of the subventricular zone (SVZ), and differentiate into mature 
oligodendrocytes (Baumann and Pham-Dinh, 2001). The transcription factors OLIG2 and 
NKX-2.2 specify the cell fate of oligodendrocyte progenitors, and OLIG2 is expressed 
throughout the oligodendrocyte lineage (Xu et al., 2000; Zhou et al., 2001). OPCs express 
markers such as the chondroitin sulfate proteoglycan AN2/NG2 (Nishiyama et al., 1996) 
and the platelet-derived growth factor receptor alpha (PDGFR) (Hall et al., 1996). Early 
myelinating oligodendrocytes express the marker BCAS1 (Fard et al., 2017). Mature 
oligodendrocytes express markers such as APC (CC-1) (Lang et al., 2013), CNP, myelin 
basic protein (MBP) (Reynolds and Wilkin, 1988), proteolipid protein (PLP/DM20) (Nave et 
al., 1987), and myelin oligodendrocyte glycoprotein (MOG) (Pham-Dinh et al., 1993). 
Myelin is rich in lipids (around 70% of the dry weight) and cholesterol, whereas other 
types of membrane are made of roughly equal amounts of proteins and lipids (Chrast et 
al., 2011; Fledrich et al., 2018; O'Brien and Sampson, 1965). Myelination is a well-
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coordinated process to assemble membrane around axons, generating compacted myelin 
that supports the function of the nervous system (Snaidero and Simons, 2014). 
 
In the most frequent demyelinating disease multiple sclerosis (MS), the damage to myelin 
causes the loss of saltatory nerve conduction and trophic and metabolic support for 
axons. Remyelination has been observed in humans in an early phase of the disease 
(Prineas et al., 1993; Prineas et al., 1989; Raine and Wu, 1993), but the regeneration is 
often not effective to prevent neurodegeneration and disability as the disease progresses 
(Franklin et al., 2012; Nave, 2010). MS is a putative autoimmune disease, supported by 
various lines of evidence for autoreactive T lymphocytes (Compston and Coles, 2008; 
International Multiple Sclerosis Genetics et al., 2011; Ludwin, 2000). Three general 
categories of experimental demyelination and remyelination models are studied to 
understand demyelinating diseases: (1) toxin-induced demyelination models cause 
damage to oligodendrocytes and primary demyelination without autoimmunity. 
Demyelination is separated from the subsequent remyelination process. The common 
reagents used to induce focal demyelination or kill oligodendrocytes are lysolecithin, 
cuprizone and ethidium bromide. (2) Autoimmune-induced models, for example, the 
experimental autoimmune encephalomyelitis (EAE) involves the immunization of animals 
with CNS antigens such as myelin proteins or the injection of an autoantibody (Franklin 
and Ffrench-Constant, 2017; Kremer et al., 2016). For instance, MOG is a membrane 
protein expressed on oligodendrocytes and the outermost surface of myelin sheaths. The 
injection of anti-MOG antibody into rats can activate endogenous complement and 
mediate demyelination (Linington et al., 1988). (3) Viral models mimic some aspects of 
MS pathology (Kremer et al., 2016). In this study, the mechanisms of remyelination were 
investigated after toxin-induced focal demyelination by the injection of lysolecithin into the 
mouse spinal cord. In this model, demyelination is complete 4 days post-injection (DPI); 
the number of microglia / macrophages in the lesions peaks at 7 DPI; remyelination is 
most prominent between 14 and 21 DPI (Cantuti-Castelvetri et al., 2018; Jeffery and 
Blakemore, 1995; Miron et al., 2013) 
 
Remyelination is a highly orchestrated process of generating new oligodendrocytes from 
OPCs and forming new myelin sheaths around demyelinated axons. In the lysolecithin 
model, the inflammatory response is the consequence of demyelination rather than the 
cause, and the depletion of macrophages using clodronate-liposomes resulted in impaired 
remyelination (Kotter et al., 2001). This is consistent with the notion that reparative 
inflammation prepares damaged tissue for regeneration (Karin and Clevers, 2016). Since 
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microglia / macrophages are the professional phagocytes in the CNS, they are most likely 
to clear damaged myelin, detect demyelination, and secrete cytokines and signaling 
molecules to activate OPCs for remyelination (Miron, 2017). Myelin debris in the lesion 
can inhibit OPC differentiation and remyelination (Kotter et al., 2006; Lampron et al., 
2015), and therefore it must be removed from the lesions. The generation of new 
oligodendrocytes is crucial, because genetic fate mapping showed that pre-existing 
mature oligodendrocytes do not contribute to remyelination (Crawford et al., 2016). In 
response to demyelination, adult OPCs change their gene expression to an immature 
state, and become activated for proliferation and migration to repopulate the lesion 
(Moyon et al., 2015). After the recruitment, OPCs differentiate into mature myelinating 
oligodendrocytes and regenerate myelin. This process is similar to developmental 
myelination in terms of the expression of oligodendrocyte markers at the corresponding 
stages, although regenerated myelin sheaths are thinner and shorter than intact myelin in 
the adult CNS (Capello et al., 1997; Ludwin and Sternberger, 1984; Morell et al., 1998; 
Sim et al., 2000). Remyelination is occasionally contributed by progenitors from the SVZ 
to nearby lesions, for instance, in the corpus callosum (Kazanis et al., 2017; Samanta et 
al., 2015; Xing et al., 2014). Astrocytes might also respond to the signals from microglia 
and secrete molecules that regulate OPCs and/or microglia (Hammond et al., 2014; 
Petkovic et al., 2016). The signals for OPC activation may also come from vascular cells 
(Arai and Lo, 2009), OPCs themselves (Moyon et al., 2015) and regulatory T cells 
(Dombrowski et al., 2017). 
 
Neuropathological studies of MS lesions showed that around 30% of lesions contain few 
OPCs, whereas 70% of lesions have sufficient OPCs but they fail to differentiate into 
mature oligodendrocytes for remyelination (Boyd et al., 2013; Lucchinetti et al., 1999). 
Therefore, finding the molecules and/or pathways that recruit OPCs to the lesions as well 
as those that promote OPC differentiation will help the development of therapy for MS. 
Many factors have been identified to regulate OPCs directly or indirectly in these phases 
of remyelination (Gaesser and Fyffe-Maricich, 2016; Swiss et al., 2011). For example, 
OPCs form new glutamatergic synapses with demyelinated axons, and the axonal activity 
can stimulate AMPA and kainite receptors, causing OPCs to differentiate (Etxeberria et 
al., 2010; Gautier et al., 2015). CCN3 derived from regulatory T cells was shown to 
promote remyelination (Dombrowski et al., 2017). It was also demonstrated that CNTF 
and LIF enhance remyelination by activating the JAK2/STAT3 pathway (Steelman et al., 
2016). LINGO-1 was identified to negatively regulate oligodendrocyte differentiation and 
myelination (Mi et al., 2005), and blocking LINGO-1 signaling improved remyelination (Mi 
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et al., 2009). The activation of ERK1/2 MAP kinases in OPCs was shown to increase the 
thickness of myelin during development (Ishii et al., 2012) and to promote remyelination 
(Fyffe-Maricich et al., 2013; Jarjour et al., 2015; Michel et al., 2015; Najm et al., 2015). 
Retinoid X receptor RXR-γ signaling was shown to promote OPC differentiation and 
remyelination by studying focal demyelination models in the rat CNS (Huang et al., 2011). 
CHD7 interacts with SOX10 and regulates myelination and remyelination (He et al., 2016). 
The transcription regulator Ascl1/Mash1 was indicated to increase oligodendrogenesis 
during development and remyelination (Nakatani et al., 2013). The important roles of 
microglia and macrophages in remyelination have been supported by the molecules 
derived from them that have effects on OPCs (Franklin and Ffrench-Constant, 2017). The 
pro-inflammatory cytokine interleukin (IL)-1β was shown to promote remyelination (Mason 
et al., 2001). In IL1b-/- mice, the lack of the secretion of IGF-1 by microglia / macrophages 
and astrocytes results in the delay of OPC differentiation and inadequate remyelination 
(Mason et al., 2003). Another pro-inflammatory cytokine TNF-α was indicated to promote 
OPC proliferation and remyelination after cuprizone-induced demyelination (Arnett et al., 
2001) and to enhance oligodendrocyte differentiation and remyelination in EAE (Madsen 
et al., 2016). The upregulation of the chemokine CXCL12 was shown to activate its 
receptor CXCR4 on OPCs, promoting OPC differentiation and remyelination (Patel et al., 
2010). Macrophage-derived endothelin 2 was identified to enhance remyelination (Yuen et 
al., 2013). The TGF- superfamily member activin-A secreted by microglia / macrophages 
was shown to induce oligodendrocyte differentiation during remyelination (Miron et al., 
2013). 
 
After microglia / macrophages internalize myelin debris, they need to clear the myelin 
debris and secrete the molecules to create a supportive environment for remyelination. 
The accumulation of myelin debris, especially cholesterol, in microglia / macrophages and 
impaired remyelination are characteristic of demyelinated lesions in old mice. Cholesterol 
transporters such as apolipoprotein E (APOE) are required for clearing myelin debris and 
resolving inflammation, and the stimulation of cholesterol efflux from the phagocytes can 
restore the remyelination capacity of old mice (Cantuti-Castelvetri et al., 2018). A study 
showed that systemic injections of amphotericin B and macrophage colony-stimulating 
factor (M-CSF) activated microglia / macrophages, increased the number of OPCs and 
promoted remyelination. The stimulated production of TNF-α by macrophages was 
abolished in absence of both MyD88 and TRIF in vitro (Doring et al., 2015). This suggests 




The myeloid differentiation primary response protein MyD88 is the canonical adaptor 
protein for the inflammatory signaling pathways of TLRs and IL-1 receptor family (Deguine 
and Barton, 2014). TLRs are a family of pattern recognition receptors (PRRs) that sense 
pathogens or endogenous damage signals and initiate innate and adaptive immune 
responses. The TLRs located in the plasma membrane have extracellular domains that 
recognize pathogen- or damage-associated molecular patterns (PAMPs or DAMPs) from 
outside the cell, whereas the TLRs located in the endosome membrane recognize signals 
of intracellular PAMPs or DAMPs in the endosome. The activation of TLRs by its ligands 
leads to the interaction of TLRs with different combinations of adaptor proteins. While 
most TLRs (except TLR3) depend on MyD88 to initiate the signaling efficiently, the 
adaptor protein TRIF can also mediate the signaling of some TLRs (Kawai and Akira, 
2006). The MyD88-mediated signaling of TLRs and IL-1 receptor family involves 
interactions among various signaling components and a series of phosphorylation and 
ubiquitination events, resulting in the activation of NF-κB and MAP kinase signaling, which 
induces the expression of inflammatory cytokines; and the activation of interferon 
regulatory factors (IRFs) for the expression of type I and III interferons (IFNs) (Ank et al., 
2008; Kawai and Akira, 2006; Onoguchi et al., 2007). In the Myd88-/- mice, the induction of 
cytokines and IFN-γ by IL-1 and IL-18 was abolished (Adachi et al., 1998), but the 
activation of NF-κB and MAP kinases in response to TLR2 and TLR4 signaling was still 
observed (Kawai et al., 1999). MyD88 is primarily expressed in microglia / macrophages 
in the CNS. The Myd88 mRNA expression levels in various cell types in the cerebral 
cortex are: microglia / macrophages 46.2712 ± 3.289 FPKM, endothelial cells 8.81965 ± 
0.42895 FPKM, OPCs 3.0818 ± 0.034 FPKM, astrocytes 3.0226 ± 0.2468 FPKM, 
myelinating oligodendrocytes 1.94655 ± 0.19675 FPKM, newly formed oligodendrocytes 
1.9381 ± 0.1961 FPKM, and neurons 1.3718 ± 0.1719 FPKM (Brain RNA-Seq) (Zhang et 
al., 2014). Therefore, microglia / macrophages are the main cell types affected by MyD88 
deficiency in the CNS. 
 
In my Ph.D. project, remyelination was examined in Myd88-/- mice to investigate the roles 
of microglia activation and inflammatory response. Fewer OPCs and impaired 
remyelination were observed in Myd88-/- mice after lysolecithin-induced demyelination. To 
understand the cause of impaired remyelination, the phagocytosis of damaged myelin, 
phagosome maturation and the clearance of internalized myelin debris by microglia were 
studied. Furthermore, the activation phenotypes of microglia during remyelination, and the 
relay of signals to regulate the responses of OPCs for remyelination were compared 
between wild-type (WT) and Myd88-/- microglia. 
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Phagocytosis is a process to internalize large particles that are ≥ 0.5 µm (Allen and 
Aderem, 1996). In metazoans, phagocytosis is a critical defense mechanism of innate 
immunity, and contributes to the maintenance of homeostasis by clearing damaged 
structures and dead cells. The particles are recognized by phagocytic receptors on the 
cell surface, which initiates signaling pathways that lead to the remodeling of actin 
cytoskeleton and the formation of phagocytic cups (Pauwels et al., 2017). The 
phagosomes containing internalized particles are moved along microtubules, and actin 
polymerizes at the phagosomal membrane (Blocker et al., 1997). During phagosome 
maturation, phagosomes interact with early endosomes and late endosomes, forming 
early phagosomes and late phagosomes, respectively, and eventually fuse with 
lysosomes, forming phagolysosomes (Pauwels et al., 2017). Phagosomes acquire the 
vacuolar-type H+-ATPases (v-ATPases), which acidifies their lumen (Lukacs et al., 1990), 
and the NADPH oxidase complex, which produces reactive oxygen species (Savina et al., 
2006). The low pH in the lumen of phagolysosomes allows optimal activity of hydrolytic 
enzymes such as cathepsins for the degradation of phagocytic cargos (Yates et al., 2005). 
Phagosome maturation is elegantly regulated at each step (Levin et al., 2016), and the 
lysosome-associated membrane glycoprotein 2 (LAMP-2) has been shown to be crucial 
for the maturation of phagosomes and autophagosomes (Beertsen et al., 2008; Huynh et 
al., 2007). Different kinetics of phagosome maturation serves different functions, 
depending on the internalized materials and the cell type. In macrophages, fast 
phagosome maturation enhances the killing of pathogens and the digestion of damaged 
materials (Yates et al., 2005); whereas in dendritic cells, delayed phagosome maturation 
allows antigen presentation of partially digested cargos to T lymphocytes (Savina and 
Amigorena, 2007). Late endosomes and lysosomes are often detected using 
LysoTracker® probes, which are weakly basic amines conjugated to a fluorophore. 
LysoTracker selectively accumulates in organelles with low luminal pH and generates 
enhanced fluorescence (Blander and Medzhitov, 2004; Kinchen and Ravichandran, 2008). 
 
Phagosome maturation is a key step to deliver internalized pathogens or damaged 
materials from phagosomes to lysosomes for degradation. It has been shown that MyD88 
is required for the phagocytosis of bacteria and phagosome maturation in macrophages. 
Bacteria, but not apoptotic cells, activated MyD88-dependent TLR signaling, which 
regulated phagosome maturation (Blander and Medzhitov, 2004). While the dependence 
of phagosome maturation on TLR2/4 signaling was controversial, Myd88-/- macrophages 
were confirmed to have impaired phagocytosis of pathogens and defective fusion of 
phagosomes and lysosomes (Henneke et al., 2002; Liu et al., 2004; Marr et al., 2003; 
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Yates and Russell, 2005). The studies of phagocytosis were performed in serum-free 
medium to exclude the effects of Fc or complement receptors (Caron and Hall, 1998; 
Underhill and Ozinsky, 2002). In this study, the phagocytosis of myelin debris and 
phagosome maturation in WT and Myd88-/- cultured microglia were analyzed, because 
they are critical for the degradation of internalized myelin debris and the activation 
phenotype(s) of microglia. 
 
The microglia isolated from healthy brains show a core gene expression profile (Bennett 
et al., 2016; Butovsky et al., 2014; Hickman et al., 2013; Wes et al., 2016). Upon 
activation, individual microglia exhibit mixed phenotypes that do not necessarily fit into 
either M1 (pro-inflammatory) or M2 (anti-inflammatory or immunoregulatory) phenotypes 
(Hanisch and Kettenmann, 2007; Ransohoff, 2016; Town et al., 2005). Microarray 
analysis of microglia after cuprizone-induced demyelination and remyelination identified 
the expression of some M1 and M2 markers, upregulation of MHC class II, and the genes 
for microglial effector functions, including phagocytosis, lipid recycling, tissue remodeling, 
and the factors that promote the recruitment or differentiation of OPCs. However, the 
study did not identify novel secreted factors or pathways that are supportive for 
remyelination (Olah et al., 2012). In contrast to bulk transcriptomics that measures the 
ensemble gene expression of a population, possibly averaging out the differences among 
subsets of microglia, single-cell transcriptomics has identified distinct microglia activation 
phenotypes in recent studies (Keren-Shaul et al., 2017). For instance, single-cell RNA 
sequencing (RNA-seq) of microglia during the progression of neurodegeneration in mice 
identified disease stage-specific cell states, including two reactive microglia phenotypes – 
the early response microglia that express the signature of type I IFN response genes, and 
the late response microglia that show the upregulation of MHC class II genes, which could 
be induced by IFN-γ (type II IFN) (Mathys et al., 2017). Pathway and network analysis of 
transcriptomic or proteomic data predicts models of regulatory networks, which could be 
potential hypotheses for mechanistic studies. For example, Ingenuity Pathway Analysis of 
the transcriptomes of the microglia isolated from mice during aging and in neurological 
disease models identified TGF-β and APOE as the major upstream regulators of the 
homeostatic phenotype and the neurodegenerative phenotype, respectively, which was 
validated by experimental evidence (Krasemann et al., 2017). 
 
The activation of microglia / macrophages in demyelinated lesions was analyzed by 
immunohistochemistry for the activation markers that are known to be relevant to 
remyelination. The ionized calcium binding adaptor molecule 1 (IBA1, encoded by the Aif1 
14 
 
gene) is a general marker for microglia and macrophages. IBA1 is involved in the Rac 
signaling pathway that regulates actin cytoskeleton dynamics, and the expression level of 
IBA1 correlates with cell activation (Imai et al., 1996; Imai and Kohsaka, 2002). Galectin-3 
(formally called MAC-2; encoded by the Lgals3 gene) is a carbohydrate-binding protein 
expressed by microglia / macrophages during remyelination. It was suggested to activate 
the phagocytosis of damaged myelin after injury (Rotshenker, 2009). Galectin-3 was also 
shown to be required for OPC differentiation and remyelination (Hoyos et al., 2014; 
Pasquini et al., 2011). The expression of major histocompatibility complex (MHC) class II 
by microglia / macrophages has been observed under physiological and pathological 
conditions. The MHC class II-positive microglia may not be involved in antigen 
presentation, for which co-stimulatory molecules are also required (Perry, 1998). The 
TNF-α-dependent induction of MHC genes was identified in microglia and astrocytes 
during remyelination, and MHC class II-null mice displayed a delay in oligodendrocyte 
regeneration and remyelination (Arnett et al., 2003). The expression of other activation 
markers could also be analyzed. For example, the inducible nitric oxide synthase (iNOS) 
catalyzes the synthesis of nitric oxide from arginine during inflammation and is considered 
an “M1” marker (Sparrow, 1994). On the other hand, arginase-1 catalyzes the conversion 
of arginine to ornithine in competition with iNOS, and it is considered an “M2” marker. The 
expression of arginase-1 in microglia is associated with the phagocytosis of apoptotic cells 
and damaged structures (Ahn et al., 2012). LAMP-2 (Mac-3 or CD107b), the lysosomal 
membrane glycoprotein required for the maturation of phagosomes and autophagosomes, 
is another activation marker of microglia / macrophages (Hagemeyer et al., 2017). 
 
To identify the molecules and pathways involved in remyelination, transcriptomic and 
proteomic studies were performed to compare the gene expression profiles of the lesions 
or cultured microglia of WT and Myd88-/- mice. Cell culture assays were established for 
the analysis of secreted molecules from microglia after the exposure to myelin debris, or 
for the analysis of microglia activation phenotype after extended exposure to myelin 
debris. The experiments were carried out in defined, serum-free medium to minimize 
artificial activation of microglia by serum (Bohlen et al., 2017). Pathway analysis of the 
proteomic data of microglial cell lysate was conducted using Ingenuity Pathway Analysis 
(IPA) and the gene ontology enrichment analysis and visualization tool (GOrilla). IPA 
predicts regulatory networks and causal relationships associated with the gene expression 
data, based on individual relationships curated from the literature. “Upstream regulators” 
are molecules that might potentially explain the observed changes in gene expression in 
the dataset. They might be interdependent and form “mechanistic networks”. The 
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statistical significance of the regulators is scored by p-value and z-score. Here, p-value is 
an enrichment score that indicates the overlap of the observed and predicted regulated 
gene sets. The activation z-score infers the activation state of a putative regulator: z < 0 
suggests an inhibited regulator, and z > 0 suggests an activated regulator (Kramer et al., 
2014). GOrilla identifies enriched gene ontology terms and visualizes the analysis as a 
hierarchical structure. It computes a p-value for the observed enrichment based on a 
theoretical characterization of the distribution (Eden et al., 2009). Candidate molecules 
identified in the transcriptomic and proteomic analyses can be tested for their effects on 
OPC proliferation, differentiation and myelination in cell culture or organotypic slice culture 
assays. 
 
Organotypic slice cultures are ex vivo models that maintain the cell populations and 
cellular architecture. Slice cultures are commonly used for studying neurodevelopment, 
brain damage and repair, and neuronal-glial interactions and so on. They are accessible 
for treatment, electrophysiology, and live imaging, etc. Slice cultures are prepared from 
early postnatal mice and are maintained using the interface method for up to one month 
(Stoppini et al., 1991). The method to deplete and replenish microglia in organotypic 
hippocampal slice culture (OHSC) provides a model for studying microglia of various 
genotypes in a culture system where they display in vivo-like ramified morphology 
(Masuch et al., 2016). Remyelination assay has been established in organotypic 
cerebellar slice culture (OCSC) and widely used for screening small molecules (Najm et 
al., 2015; Zhang et al., 2011). The assays for OPC proliferation and myelination were 
established in OHSC after comparing the responses of OHSC and OCSC. Proliferating 
cells are labeled with 5-ethynyl-2’-deoxyuridine (EdU), a thymidine analog that is 
incorporated into newly synthesized DNA (Salic and Mitchison, 2008). EdU, which 
contains an alkyne functional group, is detected by covalent linkage to a fluorophore with 
an azide group using the click reaction (Breinbauer and Kohn, 2003; Rostovtsev et al., 
2002; Wang et al., 2003). The myelination assay was established using 3,3’,5-triiodo-L-
thyronine (T3), a thyroid hormone that promotes oligodendrocyte differentiation and 
myelination (Almazan et al., 1985; Baas et al., 1997; Jones et al., 2003). In addition, toxin- 
and autoimmune-induced demyelination models were established in OHSC, which may be 
applied to study the mechanisms of demyelination and to test candidate molecules. 
 
Since remyelination often recapitulates some aspects of developmental myelination, we 
asked whether MyD88-dependent pathways are required for the proliferation and 
recruitment of OPCs for myelination during postnatal development. A subset of amoeboid 
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microglia that highly express LAMP-2 appears postnatally in the developing white matter 
of corpus callosum and cerebellum. Characterization of this microglia subset indicated the 
important roles of postnatal microglia in the development and homeostasis of OPCs 
(Hagemeyer et al., 2017). Therefore, the number of OPCs in the corpus callosum was 
analyzed at the age of the peak of amoeboid LAMP-2+ microglia to examine 
oligodendrocyte development in MyD88-deficient mice. 
 
 
Materials and methods 
Mice 
All animal experiments were performed according to the German animal welfare law and 
local regulations for animal experimentation. The Myd88-/- mice (Adachi et al., 1998) were 
generously provided by the Laboratory of Prof. Dr. Uwe-Karsten Hanisch in Göttingen. 
The Myd88-/- strain was kindly provided by the Laboratory of Dr. Arthur Liesz and bred as 




The genotype of Myd88-/- mice was confirmed by genotyping. Genomic DNA was 
extracted from the tissue of ear punches or a small fraction of the animals’ tail using the 
Invisorb® Spin Tissue Mini Kit (Stratec Molecular) according to the user manual and the 
following modifications: the tissue was lysed with 400 µL of Lysis Buffer G and 40 µL of 
Proteinase S or K (vortexed for 5 sec) at 52 °C overnight. The centrifugation to remove 
residual ethanol was done at 11000 ×g for 6 min. DNA was collected by incubation with 
100 µL of Elution Buffer for 3 min and centrifugation at 11000 ×g for 1 min. 
 
The DNA fragments were amplified by polymerase chain reaction (PCR) using GoTaq® 
G2 DNA polymerase (Promega, M7845). The genotyping protocol for the Myd88-/- strain 




Oligo Name Sequence 5' to 3' Scale (µmole) Purification 
Myd88F GTT GTG TGT GTC CGA CCG T 0.025 Desalted 
Myd88R GTC AGA AAC AAC CAC CAC CAT GC 0.025 Desalted 
The reaction mix was prepared as the following: 
Reaction mix for 1 reaction 20 µL 
Autoclaved deionized H2O 13.5 µL 
5× buffer 4 µL 
2 mM dNTP 1 µL 
10 µM Myd88F 0.2 µL 
10 µM Myd88R 0.2 µL 
GOTaq DNA polymerase 0.1 µL 
DNA 1 µL 
The reaction was done in a T3000 Thermocycler (Biometra) using the following program: 
94 °C 3 min  
94 °C 30 s 
35× 66 °C 1 min 
72 °C 1 min 
72 °C 2 min  
4 °C ∞  
 
The genotype was identified by agarose gel electrophoresis of the PCR product. The 
expected size of DNA fragment amplified from Myd88-knock out is 353 base pairs (bp), 
and 266 bp from WT. On a 2% agarose gel (prepared in 1× TAE buffer) containing 
GelRed® Nucleic Acid Gel Stain (2 µL per 150 µL of gel) (Biotium, 41003), 4 µL of PCR 
product, 4 µL of GeneRuler 100 bp DNA Ladder (Thermo Scientific™, SM0244) and 1 µL 
of TrackIt™ 25 bp DNA Ladder (Invitrogen™, 10488022) were loaded. The 
electrophoresis was run at 100-120 V for ~60 min (until the yellow band almost reached 
the end of the gel). The gel was imaged by the exposure to UV light using the gel 
documentation system, and the images were printed and exported as TIFF using the 




Stereotactic injection of lysolecithin in the spinal cord was performed in Myd88-/- mice that 
were 9-12 weeks old and age-matched wild-type C57BL/6J mice after at least 2 weeks of 
acclimatization to the animal unit. 
 
Glass Capillaries for Nanoliter 2010, fire polished 2 (World Precision Instruments, 504949 
or 4878) were pulled using the P-1000 Next Generation Micropipette Puller (Sutter 
Instrument) (in Göttingen). The program had the following parameters: Heat 530, Pull 0, 
Vel 60, Time 250, Pressure 500, Ramp 520, Microinjection – BF100.50.10, Tip < 1 µm, 
Taper 6-8 mm. R ~40-80 Meg, Heat = Ramp, FB255B, 2.5mm Box. Alternatively, the 
capillaries were pulled using the DMZ-Universal Puller (Laboratory of Dr. Bettina Schmid, 
Munich). The P(A)60 program is the following: 
HEAT H  401 T(F1)  250 DELAY  Pull1 
FORCE  Pre-pull F (TH)  025 F1  400 FORCE  Pull1 
DISTANCE  Threshold D s(TH)  028 s (F2)  010 DISTANCE  Pull2 
DELAY  Heatstop  DIST. R-Polish T (H)  006 F2  200 FORCE  Pull2 
DISTANCE  Heatstop  DIST. L-Polish s (H)  000 AD  000 ADJUST 
 
The reagents for injection were prepared under the cell culture hood. 1% lysolecithin was 
prepared by dissolving L-α-Lysophosphatidylcholine from egg yolk (Sigma, L4129) in 
PBS, pH 7.4 (Gibco™, 10010056). 3% Monastral blue was prepared by dissolving 
Copper(II) phthalocyanine-tetrasulfonic acid tetrasodium salt (Aldrich, 274011) in 
deionized water, and the solution was passed through 0.45-µm filter and autoclaved. Prior 
to injection, 1 µL of 3% Monastral blue was mixed with 25 µL of 1% lysolecithin. 
 
Before surgery, the animals were anesthetized by intraperitoneal (IP) injection with 150 µL 
of ketamine/xylazine (10 mg/mL ketamine and 1 mg/mL xylazine) or 400 µL of avertin (in 
Göttingen). Avertin was prepared by dissolving 1 g 2,2,2-tribromoethanol (Aldrich, 
T48402) in 0.81 mL of tert-amyl alcohol and 71.49 mL of deionized water by stirring and 
heating at ~40 °C. The solution was passed through a 0.22-µm filter, aliquoted, and stored 
protected from light at 4 °C for maximum 1 week or at -20 °C. Alternatively (in Munich), 
the animals were anesthetized by IP injection of 0.5 mg/kg body weight medetomidine, 5.0 
mg/kg midazolam and 0.05 mg/kg fentanyl (MMF). The anesthetized animals were kept 
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on a heating pad at 37 °C, and Bepanthen eye ointment was applied to prevent drying of 
eyes. The anesthetic depth was monitored by checking the reflex between the toes and 
the corneal reflex. 
 
The surgery and intraspinal injection of lysolecithin was conducted using the digital mouse 
stereotaxic frame and Nanoliter 2010 Injector with MICRO4 controller (World Precision 
Instruments) as previously described (Cantuti-Castelvetri et al., 2018). After the spinal 
cord was exposed, the capillary was positioned 0.55 mm lateral to the dorsal artery, and 
lowered 1.15 mm into the tissue. At each injection site, 1 µL of 1% lysolecithin containing 
0.12% Monastral blue was injected at a speed of 150 nL/min. 1 min after lysolecithin was 
delivered, the capillary was slowly retracted. After injection, the skin was sutured, and the 
wound was disinfected and sealed with the tissue adhesive Histoacryl® (B. Braun). After 
the operation, the animals were injected IP with 250 µL of 0.9% NaCl (normal saline 
solution) to compensate for the loss of blood. The analgesic buprenorphine was injected 
subcutaneously (SC) at a dose of 0.1 mg/kg. When MMF was used for anesthesia, 2.5 
mg/kg atipamezole, 0.5 mg/kg flumazenil and 1.2 mg/kg naloxone (AFN) was injected IP 
for the animals to wake up. The animals were kept on a heating pad at 37 °C until they 
were awake. They were supplied with wet powder food in a 100-mm Petri dish in addition 
to regular food and water. The wet powder food was refreshed daily until the animals’ hind 
limbs could function properly. The animals were injected SC with buprenorphine one or 




Preparation of tissue samples for histology 
The mice were fixed by transcardial perfusion to prepare samples for histology. Adult 
animals were anesthetized by IP injection with 100-200 µL of 14% chloral hydrate 
(prepared in water) (Sigma, C8383). Postnatal day (P) 7 mouse pups were anaesthetized 
by IP injection with 10 µL of MMF. The blood was washed out by transcardial perfusion 
with filtered, ice-cold phosphate buffered saline (PBS, Table 4) for 5 min until clear liquid 
came out of the right atrium and the liver turned pale. The animals were then perfused 
with fresh, filtered, ice-cold 4% paraformaldehyde (PFA) in PBS for 10-15 min (adult mice) 
or 3-5 min (P7 pups) until the animals stiffened. The brain was taken out of the skull and 
post-fixed in 4% PFA at 4 °C overnight (adult brains) or for maximum 6-8 h (pup brains). 
The spine was taken out. The bones on the ventral side were removed to expose the 
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ventral spinal cord, and then the spine was fixed in 4% PFA at 4 °C for 3-6 days. If only 
the spinal cord was needed for histology, the mice were anesthetized by IP injection with 
chloral hydrate or in a CO2 chamber, and euthanized by decapitation. The spine was 
dissected and fixed in the same way. 
 
After post-fixation, the tissue was washed in PBS and processed for cryoprotection. The 
tissue not required for processing could be stored in PBS containing 0.1% sodium azide at 
4 °C. The spinal cord was dissected out of the bone. The brain and spinal cord were 
immersed in 30% sucrose (prepared in PBS on the day of use) at 4 °C for 3 days, until the 
tissue sank to the bottom of the Conical tube. The tissue was immersed in 1:1 mixture of 
30% sucrose in PBS and Tissue-Tek® O.C.T. Compound (Sakura) at room temperature 
(RT) with shaking at 400 rpm overnight. The tissue was transferred to O.C.T. and 
incubated at RT for 4-5 h (spinal cord) or 1 day (brain). Afterwards the tissue was 
embedded in O.C.T. on dry ice. The frozen tissue was stored at -20 or -80 °C. 
 
Coronal sections of spinal cords and brains were cut at a thickness of 12 µm using a 
cryostat. The sections were mounted on SuperFrost™ Plus Microscope Slides (Thermo 
Fisher Scientific). The adjacent spinal cord sections were mounted on alternating slides so 
that in each pair of slides, one slide was used for immunohistochemistry whereas the 
other was used for luxol fast blue stain. The slides were stored at -20 or -80 °C. 
 
 
Luxol fast blue and periodic acid-Schiff (LFB-PAS) stain 
0.1% luxol fast blue (LFB) was prepared by dissolving 0.4 g solvent blue 38 (Carl Roth, 
7709.2) in 400 mL of 95% ethanol and 2 mL of acetic acid (glacial). The solution was 
filtered. The slides of mounted sections were dried in a 37 °C incubator for 30 min, and 
washed with PBS for 5 min on a shaker. The sections were immersed in deionized water 
for 5 min (to remove the salts), and dehydrated in 50%, 70%, 90% and 100% ethanol for 5 
min each. The sections were incubated with 0.1% LFB in a glass container tightly 
wrapped with aluminum foil (to avoid the evaporation of ethanol) overnight at 57 °C. The 
slides were cooled to RT. For the differentiation of white and gray matters, 50 mL of each 
of the following solutions were prepared freshly in deionized water: 95% ethanol, 0.05% 
lithium carbonate (Sigma, 13010) (heated slightly to dissolve), and 70% ethanol. In a 50-
mL Conical tube, dipped a slide in 95% ethanol and rinsed with distilled water. The slide 
was then dipped 5 times in 0.05% Li2CO3, dipped 5 times in 70% ethanol, and rinsed with 
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distilled water (Kluver and Barrera, 1953). The slide was examined under the microscope. 
If white and gray matters were not distinguishable, the cycle was repeated by dipping 
once or twice in each solution. After this step, the slides were kept in PBS. 
 
After LFB stain, PAS stain was used to detect polysaccharides on inflammatory cells. 
0.5% periodic acid (P0430) was prepared freshly in deionized water. The slides were 
washed with distilled water for 2 min on a shaker, incubated with fresh 0.5% periodic acid 
for 10 min, and washed 3 times for 2 min each with deionized water. The slides were then 
incubated with Schiff’s reagent (Merck Millipore, 1.09033.0500) (protected from light) for 
15 min, and washed 3 times for 2 min with deionized water (protected from light). 
Afterwards the slides were left in a container under running distilled water from the tap for 
15 min. 
 
After LFB-PAS stain, the slides were dehydrated in 90% ethanol for 1 min, in 100% 
ethanol for 1 min, and in xylene for at least 5 min under the fume hood for histology. The 




The spinal cord was sectioned using a vibratome (Leica Biosystems): longitudinal sections 
were cut for the dissection of lesions for RNA sequencing; coronal sections were cut to 
prepare samples for semithin sections. 20% gelatin was prepared by dissolving gelatin 
powder (Merck Millipore, 1040781000) in PBS by stirring and heating at 60 °C. Before 
vibratome sectioning, the aliquots of 20% gelatin were thawed from -20 °C and heated at 
37 °C with shaking. A segment of spinal cord (shorter than 3 mm) was freshly dissected 
from the mouse, and embedded in 20% gelatin in an embedding mold (Sigma, E4140-
1EA) on ice. 200-µm coronal sections were cut at a speed of 0.4-0.5 mm/s. The coronal 
sections were fixed with K & S (4% PFA and 2.5% glutaraldehyde in K & S buffer) under a 




The semithin sections were prepared and stained, and the images were acquired by Dr. 
Ludovico Cantuti-Castelvetri. The spinal cord sections were embedded in Epon and cut at 
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a thickness of 500 nm using the Leica Ultracut S ultramicrotome (Leica). Semithin 




Preparation of myelin and non-myelin membrane 
Myelin and non-myelin membrane were isolated from the brains of 12 adult (at least 8 
weeks old) wild-type C57BL/6 mice using the Beckman Optima XL-80 Ultracentrifuge with 
the SW 28 swinging-bucket rotor. The Ultra-Clear™ Thinwall 38.5 mL Tubes (Beckman 
Coulter, 344058) were sterilized with UV under the laminar hood. The HEPES-EDTA 
buffer was prepared as 10 mM HEPES and 5 mM EDTA, pH 7.4, filtered and stored at 4 
°C. 0.32 M and 0.85 M sucrose solutions were prepared freshly in cold 10 mM HEPES, 
pH 7.4 (HEPES buffer) and filtered. Deionized water was also filtered and kept cold. 
 
The mice were euthanized in a CO2 chamber followed by decapitation. 3 or 4 brains were 
put in a Dounce homogenizer containing 4 mL of HEPES buffer. The brains were first 
homogenized mechanically using the Dounce tissue grinder set. The homogenate was 
transferred to a conical tube and topped up to 5 mL with HEPES buffer. The homogenate 
was then sonicated for 5 min using the Sonifier W-250 D (Branson). The brain 
homogenate was stored at -20 °C. 
 
The isolation and purification of myelin and non-myelin fraction were done at 4 °C or on 
ice. 5 mL of brain homogenate was overlaid on a stepwise 0.32 / 0.85 M sucrose gradient 
in an ultracentrifugation tube. The first centrifugation was done at 23800 rpm (54000 ×g) 
for 35 min. The myelin fraction was collected from the interphase using a P1000 pipet, 
whereas the non-myelin fraction in the pellet was resuspended with PBS. Deionized water 
was added to the myelin and non-myelin fractions to remove small membrane fragments 
by osmotic shock. Myelin and non-myelin fraction were pelleted by centrifugation at 23800 
rpm (54000 ×g) for 18 min. The supernatant was aspirated carefully, and the pellets were 
resuspended with water. Myelin and non-myelin fraction were washed with water and 
centrifuged at 9500 rpm (9000 ×g) twice for 18-22 min. The supernatant was removed; 1 
mL of HEPES buffer was added to each pellet, and the pellets were kept at -20 °C until 
the purification steps. The crude products of myelin and non-myelin fraction were purified 
by repeating the stepwise density gradient centrifugation, osmotic shock and two washing 
steps. The HEPES buffer for cell culture was prepared from the 1 M HEPES (Gibco™, 
23 
 
15630056), and the pH was measured by pH-indicator strips (Merck Millipore, 109543) 
and adjusted to 7.4 with sodium bicarbonate 7.5% solution (Thermo Fisher Scientific, 
25080). Each final pellet was resuspended with 500 µL of HEPES buffer for cell culture. 
The myelin and non-myelin fraction were passed through a syringe attached to a 27G 
cannula. The concentration of proteins in myelin and non-myelin fraction were measured 




The purity of non-myelin fraction was checked by western blotting for myelin basic protein 
(MBP). The proteins in myelin and non-myelin fraction were separated by polyacrylamide 
gel electrophoresis (PAGE) at a constant voltage of 100 V in stacking gel and 120 V in 
13% resolving gel, and transferred to nitrocellulose membrane at a constant current of 
350 mA for 1.5 h. After blocking with 5% milk in PBST (PBS containing 0.05% Tween-20) 
for 1 h at RT, the membrane was incubated with polyclonal rabbit anti-human MBP 
(1:2500, Dako, A0623) primary antibody in 5% milk in PBST overnight at 4 °C. The 
membrane was washed three times with PBST for 10 min, and then incubated with HRP-
conjugated goat anti-rabbit IgG secondary antibody (1:5000, Jackson ImmunoResearch) 
in 5% milk in PBST for 1 h at RT, followed by at least three times of washing with PBST 
for 5 min. The membrane was incubated with ECL substrate for 1 min on a shaker, 
exposed to autoradiograph film for 5 min and developed. 
 
 
Fluorescent labeling of myelin and non-myelin membrane 
Myelin and non-myelin membrane were labeled using the PKH67 Green Fluorescent Cell 
Linker Mini Kit (Sigma, MINI67). For each 200-300 µg myelin or non-myelin fraction in 250 
µL HEPES buffer for cell culture, a mixture of 750 µL of Diluent C and 4 µL of PKH67 
(vortexed for mixing) was added. The mixture was incubated for 5 min at RT (protected 
from light) and centrifuged at 15000 ×g for 10 min at 4 °C. The pellet was resuspended 




Fluorescence of PKH67-labeled myelin and non-myelin membrane 
The fluorescence of PKH67-labeled myelin and non-myelin fraction was measured at an 
excitation wavelength of 485 nm and emission wavelength of 535 nm using the Perkin 
Elmer Wallac 1420 Victor2™ microplate reader. The samples of labeled myelin and non-
myelin fraction were diluted to a protein concentration of 1 and 0.1 µg/mL by serial 
dilution, and the fluorescence emission was measured in quadruplicates. 
 
 
Microglial cell culture, macrophage culture, and myelin treatment 
Primary microglial cell culture was prepared by the shake of mixed glial culture in the first 
half of my doctoral study. We switched to the culture of microglia isolated by magnetic-
activated cell sorting (MACS), where the morphology of the cells looked more similar to 
microglia in vivo. In both culture methods, microglia were cultivated in the 
DMEM/FCS/L929 medium (components see Table 1) until the cells were ready for 
experiment. The microglia (shake) cultures were treated in DMEM/FCS medium. The 
MACS microglia cultures were preferably washed and incubated with the serum-free TCC 
(or TIC) medium for 3 h to overnight before experiment, and treated in TCC medium 
(Bohlen et al., 2017). To improve the attachment of cells, No. 1.5 coverslips were treated 
with hydrochloric acid (fuming) overnight, washed at least 10 times with distilled water, 
dried and disinfected at 200 °C for 6 h. Glass coverslips were coated with 0.01% poly-L-
lysine (PLL) for 1 h at 37 °C and washed twice with PBS for 5 min for microglia culture. 
Growth of microglia in plastic plates did not require any coating. The cultures were 
maintained under standard cell culture conditions at 37 °C with 5% CO2. 
 
Table 1. The media for the cultures of primary microglia, mixed glial culture, bone marrow-derived 
macrophages and L929 cell line, treatment, and live cell imaging. 
Medium Components 
DMEM/pyruvate medium DMEM (Gibco™, 41965) 
1 mM sodium pyruvate (100 mM sodium pyruvate, 
Thermo Fisher Scientific, 11360) 
DMEM/FCS medium DMEM/pyruvate medium 




Pen/strep (1:200) (penicillin-streptomycin, Gibco™, 
15070063) 
DMEM/FCS/L929 medium DMEM/FCS medium 
L929 cell-conditioned medium (1:5) 
TCC medium DMEM/pyruvate medium 
2 ng/mL TGF-β2 (Peprotech, 100-35B) 
20 ng/mL CSF1 (M-CSF, Peprotech, 315-02) 
1.5 µg/mL cholesterol (Avanti Polar Lipids (Otto 
Nordwald), 700000P) 
Pen/strep (1:200) 
TIC medium DMEM/pyruvate medium 
2 ng/mL TGF-β2 
100 ng/mL IL-34 (R&D Systems, 5195-ML-010/CF) 
1.5 µg/mL cholesterol 
Pen/strep (1:200) 
BME medium Basal Medium Eagle (BME) (Gibco, 41010) 
10% horse serum (HS) (Gibco, 26050088) 
1× GlutaMAX (Thermo Fisher Scientific, 35050) 
Pen/strep (1:200) 
Super Sato DMEM 
1 mM sodium pyruvate 
1× B-27™ supplement, serum free (Gibco, 17504044) 
1% HS 
0.5 µM L-3,3’,5-triiodothyronine 
0.5 µM L-thyroxine (Calbiochem) 
Pen/strep (1:200) 
DMEM/M-CSF DMEM/pyruvate medium 
10 ng/mL M-CSF (Butovsky et al., 2014) 
TCC/HEPES/FluoroBrite FluoroBrite™ DMEM (Gibco, A1896701) 




1.5 µg/mL cholesterol 
1× GlutaMAX 
1 mM sodium pyruvate 
20 mM HEPES (1 M HEPES, Gibco™, 15630056) 
DMEM for secretome 
analysis 
DMEM, high glucose, no glutamine, no phenol red 
(Gibco™, 31053028) 
1 mM sodium pyruvate 
1× GlutaMAX 
 
MACS microglial cell cultures were prepared from the brains of P9-P10 mouse pups, 
when the number of microglia was high and the dissociation of brain tissue was relatively 
easy. P6-P8 brains yielded fewer cells but also worked. Cell suspension was obtained by 
automated dissociation using the Neural Tissue Dissociation Kit (P) (Miltenyi Biotec, 130-
092-628) and the gentleMACS™ Dissociator (Miltenyi Biotec, 130-093-235) following the 
datasheet of the kit with some modifications. 2 or 3 brains were transferred to each C 
Tube (Miltenyi Biotec, 130-096-334). DMEM/pyruvate medium was used instead of HBSS 
during tissue dissociation. All media were warmed up to RT. The gentleMACS programs 
for the brain were run twice per tube. The optional centrifugation steps were included in 
the protocol. For the filtering of cell suspension through 70 µm cell strainers (Corning, 
352350), 5 mL of cell suspension was applied to one cell strainer and washed with 5 mL 
of DMEM/pyruvate medium. After filtering, the cell suspension was centrifuged at 300 ×g 
for 15 or 20 min. The cells were resuspended and topped up to 20 mL, and the sample 
was diluted 1/10 for counting the cell number using a hemocytometer. The cell suspension 
was centrifuged again at 300 ×g for 15 or 20 min. The myelin removal step was omitted. 
Microglia were isolated by magnetic labeling with CD11b MicroBeads (Miltenyi Biotec, 
130-093-634). DMEM/FCS medium instead of the buffer was used, and the serum was 
needed to block nonspecific binding. After the incubation with beads on ice, the cells were 
washed with 2 mL of DMEM/FCS medium per 107 cells, and centrifuged at 300 ×g for 12-
15 min at 4 °C. The pellet was resuspended in 500 µL of DMEM/FCS medium per 107 
cells. CD11b+ cells were separated from the other cells in LS columns (Miltenyi Biotec, 
130-042-401) and QuadroMACS Separator (Miltenyi Biotec). After magnetic separation, 
CD11b+ cells were flushed out in DMEM/FCS/L929 medium. The cells were counted, 
diluted to the desired density and volume in DMEM/FCS/L929 medium and seeded in 




Table 2. Seeding of microglial cell cultures. 
Method Plate / slide Cell number per well Volume of medium Minimum volume 
MACS 
48-well plate 7×104-1×105 250 µL 190 µL 
µ-slide 8 well 9×104-1×105 300 µL 150 µL 
6-well plate 8×105-1.2×106 2.5 mL 1 mL 
Shake 
48-well plate 2.5×104 250 µL 190 µL 
24-well plate 5×104 500 µL 380 µL 
 
Microglial cell cultures used to be prepared by shaking mixed glial cultures. Mixed glial 
cultures were prepared from P1-2 NMRI or C57BL/6 mouse pups. One 75cm² culture flask 
per brain was coated with 0.01% PLL for 1 h at 37 °C, washed twice with PBS, and 
incubated with BME medium (Table 1) overnight at 37 °C. After the brains were dissected 
out, meninges were removed in warm Hank’s Balanced Salt Solution (no calcium, no 
magnesium) (HBSS, Gibco). The hemispheres and midbrains were incubated with 0.25% 
trypsin-EDTA (Gibco, 25200) at 37 °C for 10 min. After trypsinization, the brains were 
transferred to the BME medium and triturated to get a single-cell suspension. The 
suspension was filtered with a 40µm cell strainer (Corning, 352340) and washed with 2 
mL of BME medium. The cell suspension was distributed to coated 75cm² flasks 
containing 5 mL of BME medium and 5 mL of super Sato (Table 1). If the cultures were 
maintained for oligodendrocyte culture, the medium was exchanged and microglia were 
washed off until the culture had enough oligodendrocytes. After the shaking of 
oligodendrocytes, the cultures were incubated with DMEM/FCS/L929 medium for 6 days 
until microglia reached ~80% confluency. The cultures were shaken at 120 rpm at 37 °C 
for 1-2 h. The cells were collected by centrifugation at 800 rpm (Centrifuge 5702R, 
Eppendorf) for 10 min at RT. The pellet was resuspended in DMEM/FCS medium. 
Microglia were seeded in multiple well plates or dishes at the desired density (Table 2). 
 
Bone marrow-derived macrophages (BMDM) were prepared as described before (Cantuti-
Castelvetri et al., 2018). The femur and tibia of adult C57BL/6 and Myd88-/- mice were 
isolated and cut at both ends. The bone marrow was flushed out with DMEM using a 
syringe. A single-cell suspension was made from bone marrow by pipetting and was 
filtered by a cell strainer. In 24-well plates, 4.5×104 cells in 1 mL of DMEM/FCS/L929 
medium were seeded per well. The macrophage cultures were prepared by Dr. Ludovico 
Cantuti-Castelvetri. The cells were washed and the DMEM/FCS/L929 medium was 
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renewed every 2 or 3 days. After 4 days in vitro (DIV), the macrophage cultures were 
washed with DMEM and treated with the reagent in DMEM/M-CSF (Table 1). 
 
The conditioned medium of L929 cell line contains factors such as M-CSF that stimulate 
the growth of microglia and macrophages. L929 cells were cultured in DMEM/FCS 
medium. The medium was renewed every 2 or 3 days. L929 cells were split at a sub-
cultivation ration of 1:2 to 1:8 three times to obtain cultures in 10 175cm2 flasks. The 
medium was conditioned with confluent L929 cultures for 10-14 days. L929 cell-
conditioned medium was collected and passed through a 0.22 µm filter. The aliquots were 
stored at -20 °C. 
 
 
Live cell imaging 
Microglia were isolated by MACS and seeded in PLL-coated µ-slides 8 well ibiTreat (ibidi, 
80826) for live cell imaging (Table 2). The cells were cultured in DMEM/FCS/L929 
medium to 90% confluency for 4-7 days, washed twice with DMEM/pyruvate to remove 
residual serum, and then incubated with serum-free TCC medium overnight (Table 1). 
The TCC/HEPES/FluoroBrite medium (Table 1) was used for live cell imaging 
experiments. FluoroBrite DMEM™ is a clear medium with low background fluorescence. 
The medium was supplemented with 20 mM HEPES to maintain the pH 7.4 (as in the Live 
Cell Imaging Solution, Invitrogen™, A14291DJ). Before treatment, the cell membrane and 
nuclei were pre-labeled by the incubation with 1 µg/mL cholera toxin subunit B (CT-B) 
Alexa Fluor™ 647 conjugate (Invitrogen™, C34778) and 10 µg/mL Hoechst 33342 
(Invitrogen™, H3570) for 15min. Microglia cultures were treated with 30 µg/mL PKH67-
labeled myelin (pulse) and 40 nM LysoTracker™ Red DND-99 (Invitrogen™, L7528) for 
15 min. After treatment, the medium was changed to TCC/HEPES/FluoroBrite, and the 
cells were incubated for 60 min (chase) before imaging. The images were acquired using 
a Leica SP5 confocal microscope. Tile scans were made with the 63× oil objective, 
pinhole 1 airy unit and zoom factor 1.5. The pre-labeling of cell membrane with CT-B 
could minimize nonspecific binding of CT-B to myelin membrane. LysoTracker was used 
before the chase to preserve the signal and avoid the accumulation of excessive 




Organotypic hippocampal slice culture and ex vivo demyelination models 
Organotypic hippocampal slice culture (OHSC) was prepared at a thickness of 375 µm 
using the interface method as described (Masuch et al., 2016). The cultures were 
prepared from the brains of P2 C57BL/6 mouse pups to have the same timing of 
myelination in culture. Hippocampal slices were cultured on small pieces of LCR 
membrane filter (Merck Millipore, FHLC04700) placed on Millicell cell culture inserts 
(Merck Millipore, PICM03050). LCR membrane was put in a big glass dish, wet with 
deionized water, flattened, air-dried, and then cut into small pieces of around 5 mm × 6 
mm using a scalpel. The confetti LCR membrane was autoclaved in the dish. In a 6-well 
plate, 0.7-1 mL of OHSC culture medium (Table 3) was pipetted in each well. Cell culture 
inserts were placed in the wells, and 3 or 4 pieces of confetti LCR membrane were placed 
carefully on each insert (bubbles should be avoided). The plates were conditioned in the 
cell culture incubator for at least 2 h. Medium A was kept at 4 °C. The MCILWAIN Tissue 
Chopper, stereomicroscope and dissection tools were disinfected with 70% ethanol and 
UV under a laminar hood. The brain was dissected out and transferred immediately to ice-
cold Medium A in a 60-mm culture dish placed on ice. Under the microscope, the 
interhemispheric fissure was cut, and the hemispheres were separated from the midbrain 
with Dumont #5 fine forceps, tilted at ~45° angle. The hemisphere was positioned with the 
inner medial site facing up. Residual midbrain or meninges were carefully removed to 
expose the hippocampus without distorting it. Cuts were made with forceps in the middle 
of the cortex along the hippocampus, leaving a piece of cortex was attached. After the 
hippocampus was dissected out, it was transferred to the platform of the tissue chopper 
with a cut transfer pipette (Thermo Fisher Scientific, 232-1S). The liquid was removed 
from the stage with a transfer pipette with a fine tip. The platform was rotated and fixed to 
place the hippocampus perpendicular to the blade. After cutting at 375 µm, the slices were 
transferred with a cut transfer pipette to a dish containing Medium A on ice. The slices 
with clear hippocampal structures were selected and transferred to confetti LCR 
membrane in the plate. OHSC was maintained at 37 °C with 5% CO2. The culture medium 
was changed the day after culture preparation, and then every 2 or 3 days. After 7 DIV, 
OHSC recovered from the culture preparation and were ready for experiments (Masuch et 
al., 2016). Myelination was mostly completed after 13 DIV but continued slowly afterwards 
(data not shown). Therefore, demyelination models were induced in DIV13 OHSC. 
 
The assay for the effects of molecules on myelination in OHSC was established using 
3,3’,5-triiodo-L-thyronine (T3) (Sigma-Aldrich, T6397) as a positive control. OHSC was 
treated with 40 or 80 ng/mL T3 in the culture medium from 7 DIV for 5 days. 
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Table 3. Components of the OHSC culture medium and the Medium A for OHSC preparation. 
OHSC culture medium 100 mL Concentration 
MEM (10×), no glutamine, with Earle’s 
salts (Gibco, 21430) 
5 mL 50% 
BME, Earle’s salts (Gibco, 41010) 5 mL 5% 
Horse serum 25 mL 25% 
GlutaMAX™ supplement (100×) (Gibco, 
35050) 
1 mL 1× 
45% glucose (Sigma, G8769) 1.44 mL 0.648% 
7.5% NaHCO3 Adjust pH to 7.2, measured 
by pH test strips 
 
Penicillin/streptomycin 0.5 mL  
Autoclaved deionized water To 100 mL  
 
Medium A 514 mL Concentration 
HBSS 1× (Gibco, 14175) 500 mL  
HEPES (1 M) (Gibco, 15630-080) 7.5 mL 15 mM 
45% glucose 6.5 mL 0.57% 
 
 
Demyelination was induced by the injection of 0.5 mg/mL in DIV13 OHSC using the 
Nanoliter 2010 Injector with MICRO4 controller (World Precision Instruments) installed on 
an MM 33 micromanipulator (Science Products). The capillaries were pulled in the same 
way as for stereotactic injection. To identify the injection site and the region where the 
injected reagent diffused to, lysolecithin was labeled with 1 µM PKH26 (PKH26 red 
fluorescent cell linker mini kit, Sigma, MINI26) in PBS. To induce a small demyelinated 
lesion in the hippocampal slice, 50 nL of 0.5 mg/mL lysolecithin was injected at a speed of 
0.100 nL/min at a depth of 150 µm from the surface; 1 min after injection, the capillary was 
retracted carefully. The injection was performed under a cell culture hood. The OHSC was 




Autoimmune demyelination model in OHSC was established with anti-MOG Z2 antibody 
and guinea pig complement. The anti-MOG Z2 mouse antibody and humanized 8-18C5 
antibody were generously provided by the Laboratory of Prof. Dr. Edgar Meinl. The first 
trial used 10 µg/mL Z2 (Elliott et al., 2012) or 8-18C5 (Linnington et al., 1984) antibody. Z2 
induced more demyelination (data not shown) than 8-18C5, and thus the demyelination 
model using Z2 was further optimized. Mouse IgG2aκ (mIgG2aκ, Sigma, M7769) (Derfuss 
et al., 2009) was used as an isotype control antibody. The batch of the complement sera 
from guinea pig (gpC) (Sigma, S1639) had a hemolytic titer of 216 CH50 units/mL. 
Demyelination was induced by the treatment of DIV13 OHSC with 10 µg/mL anti-MOG Z2 
antibody and 5% guinea pig complement in the culture medium for 72 h. The depletion of 
microglia in OHSC was done by the treatment with 100 µg/mL clodronate (Calbiochem, 




Immunohistochemistry (IHC) of lesions was conducted on mounted spinal cord sections 
due to the fragile property of lesions. To help the attachment of mounted cryosections to 
the slides, the slides were dried in a 37 °C incubator for 30 min (or at RT for at least 1 h) 
and washed twice with PBS for 5 min. A circle was drawn around each section with a 
Super PAP Pen Liquid Blocker Mini (Science Services, N71312) for the incubation with 
solution. For the IHC for cytoplasmic proteins (BCAS1, IBA1, galectin-3, MHC class II, 
GFAP, etc.), the sections were blocked and permeabilized with blocking solution 
containing 0.1% Triton X-100 for 1 h at RT. The sections were incubated with primary 
antibodies in blocking solution containing 0.1% Triton X-100 overnight at 4 °C (one section 
incubated without primary antibodies as a control for the specificity of secondary 
antibodies), and washed three times with PBS for 10 min. The sections were then 
incubated with secondary antibodies in blocking solution containing 0.1% Triton X-100 for 
1-2 h at RT, following by a wash with PBS for 10 min. Mild permeabilization using 0.1% 
Triton X-100 was required for FluoroMyelin stain. After the incubation with secondary 
antibodies, the sections were incubated with 1:350 FluoroMyelin™ Green Fluorescent 
Myelin Stain (Molecular Probes™, F34651) in PBS for 20 min at RT. The nuclei were 
stained with 1 µg/mL 4’,6-diamidino-2-phenylindole (DAPI) in PBS for 15-30 min at RT. 
The sections were washed twice with PBS for 10 min, mounted with Mowiol or ProLong™ 
Diamond Antifade Mountant (Thermo Fisher Scientific, P36970) and #1.5 coverslip, and 
air-dried overnight. The IHC for OLIG2, NKX-2.2 and APC (CC-1) required heat-induced 
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antigen retrieval in 10 mM sodium citrate, pH 6.0. The sections were heated using the 120 
°C autoclaving program for liquid. After cooling down, the sections were washed twice 
with PBS for 10 min, and permeabilized with blocking solution containing 0.3% Triton X-
100 for 1 h at RT. The sections were incubated with primary antibodies blocking solution 
containing 0.1% Triton X-100 for 2 days at 4 °C; this longer incubation allows optimal 
staining of all oligodendrocyte-lineage cells with the anti-OLIG2 antibody. After washing, 
the sections were incubated with secondary antibodies in blocking solution containing 
0.1% Triton X-100 for 2 h at RT, and the other procedures were the same as for 
cytoplasmic antigens. The dilutions of primary and secondary antibodies for IHC are listed 
in Table 5 and Table 6, respectively. 
 
The IHC of cultured organotypic hippocampal slices were carried out as a free-floating 
protocol with the slices on confetti LCR membrane. The slices were washed three times 
with warm PBS, fixed with 4% PFA in PBS for 2 h at RT, and washed three times with 
PBS for 5 min with mild shaking. For the IHC for MBP, neurofilament heavy polypeptide 
(NF-H) and IBA1, the slices were blocked and permeabilized with blocking solution 
containing 0.1% saponin and 0.02% sodium azide (block/saponin/NaN3) for 1 day at RT 
with mild shaking. To stain most part of the thick slices, the slices were incubated with 
primary antibodies in block/saponin/NaN3 for 7 days at 37 °C with shaking. The slices 
were washed six times with PBS for 30 min at RT, incubated with secondary antibodies in 
block/saponin/NaN3 for 1 day at 37 °C, and then washed three times with PBS for 30 min 
at RT. The nuclei were stained with 1 µg/mL DAPI in PBS for 30 min at RT. After two 
washes with PBS for 30 min, the slices on confetti LCR membrane were mounted on 
SuperFrost Plus slides with mounting medium and #1.5 coverslip (Figure 14D and E, and 
Figure 15). The IHC protocol was modified from the whole-mount immunostaining method 
(Belle et al., 2014). On the other hand, the staining for myelin debris (MBP) inside 
microglia (IBA1) after the injection of lysolecithin in OHSC was done at 4 °C without 
excessive washing. After fixation, the slices were blocked ant permeabilized with blocking 
solution containing 0.1% Triton X-100 for 1 day at 4 °C with mild shaking, and then 
incubated with primary antibodies (anti-MBP mouse and anti-IBA1 rabbit antibodies) in 
blocking solution containing 0.1% Triton X-100 for 6 days at 4 °C. After three washes with 
PBS for 10 min at RT, the slices were incubated with secondary antibodies in blocking 
solution containing 0.1% Triton X-100 overnight at 4 °C. The slices were then washed with 
PBS for 10 min at RT, incubated with 1 µg/mL DAPI for 15 min, washed twice with PBS 




Table 4. Buffers and solutions for immunohistochemistry and immunocytochemistry. 
Solution Components 
PBS (pH 7.4) 137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
Deionized water 
Citrate buffer (pH 6.0) 10 mM sodium citrate 
Deionized water 
Blocking solution 2.5% bovine serum 
2.5% BSA 
2.5% fish gelatin (Sigma, G7765) 
PBS 
10% blocking solution 1% bovine serum 
1% BSA 
1% fish gelatin 
PBS 
Block/saponin/NaN3 Blocking solution 
0.1% saponin (Sigma, S4521) 
0.02% sodium azide 
 




Anti-APC (Ab-7) mouse mAb (CC-1) (Calbiochem®, 
OP80) 
1:100 Antigen retrieval 
Anti-Bcas1 rabbit polyclonal antibody 1:300 Mild 
permeabilization 





Anti-GFAP polyclonal guinea pig antiserum (SYSY, 
173004) 
1:500  




Anti-myelin basic protein rat monoclonal IgG2a antibody 
(Abcam, ab7349) 
1:100 0.1% saponin 
Purified anti-myelin basic protein, clone SMI 94, mouse 
IgG1 κ (BioLegend, 836504) 
1:500  
Anti-mouse MHC class II (I-A/I-E) purified rat IgG2b κ 
(Affymetrix eBioscience, 14-5321) 
1:100 Mild 
permeabilization 
Anti-neurofilament heavy polypeptide chicken polyclonal 
IgY antibody (Abcam, ab4680) 
1:1000  
Nkx2.2 mouse hybridoma, clone 74.5A5 (DSHB, U Iowa) 1:5 Antigen retrieval 
Anti-Olig-2 rabbit polyclonal antibody (Chemicon®, 
AB9610) 
1:250 Antigen retrieval 
 
Table 6. Secondary antibodies used in IHC. 
Antibody Dilution 
Goat anti-rabbit IgG (H+L) cross-adsorbed secondary antibody, Alexa 
Fluor 647 (Thermo Fisher Scientific, A-21244) 
1:1000-
1:750 
Goat anti-rabbit IgG (H+L) cross-adsorbed secondary antibody, Alexa 
Fluor 555 (Thermo Fisher Scientific, A-21428) 
1:1000 
Goat anti-rabbit IgG (H+L) cross-adsorbed secondary antibody, Alexa 
Fluor 488 (Thermo Fisher Scientific, A-11008) 
1:1000 
Goat anti-rat IgG (H+L) cross-adsorbed secondary antibody, Alexa Fluor 
488 (Thermo Fisher Scientific, A-11006) 
1:1000-
1:750 
Goat anti-mouse IgG (H+L) cross-adsorbed secondary antibody, Alexa 
Fluor 647 (Thermo Fisher Scientific, A-21235) 
1:1000 
Goat anti-mouse IgG (H+L) cross-adsorbed secondary antibody, Alexa 





Goat anti-chicken IgY (H+L) secondary antibody, Alexa Fluor 647 (Thermo 
Fisher Scientific, A-21449) 
1:1000 
Goat anti-guinea pig secondary antibody, Cy3 1:500 
 
Immunocytochemistry 
The cells cultured on coverslips were washed with warm PBS, fixed with 4% PFA in PBS 
for 10-15 min at RT, and washed three times with PBS for 5 min. To analyze the amount 
of PKH-labeled myelin or non-myelin membrane in microglia, the cells were blocked with 
blocking solution for 30 min without permeabilization. The cell membrane was stained with 
lectin in 10% blocking solution for 45 min, and washed with PBS for 5 min. After the 
counterstain with 1 µg/mL DAPI in PBS for 15 min at RT, the coverslips were washed 
twice with PBS and once with distilled water, dried quickly and mounted on slides (Figure 
4A-C). The immunocytochemistry (ICC) for cell surface antigens galectin-3 and MHC 
class II was also done without permeabilization. After blocking, the cells were incubated 
with primary antibody in 10% blocking solution for 1 h, and washed three times with PBS 
for 5 min. The cells were incubated with secondary antibody in 10% blocking solution for 
45 min-1 h (Figure S1A and B). After microglia were treated with PKH67-labeled myelin, 
the fixed cells were stained for LAMP-2 with the anti-CD107b primary antibody. Blocking 
and permeabilization, and the incubations with primary antibody and secondary antibody 
(and lectin) were carried out in blocking solution containing 0.05% saponin (Figure 7). 
Saponin allows mild permeabilization by removing cholesterol in the cell membrane 
(Scheffler et al., 2014). The ICC for iNOS of microglia after the treatment with myelin-
PKH67 was also done with 0.05% saponin for mild permeabilization (Figure S1C). 
 
Table 7. Primary antibodies used in ICC. 
Antibody Dilution Notes 




Anti-mouse MHC class II (I-A/I-E) purified rat IgG2b κ 
(Affymetrix eBioscience, 14-5321) 
1:200 No 
permeabilization 
Purified rat anti-mouse CD107b (LAMP-2), clone M3/84, 
IgG1 κ (BD Pharmingen, 553322, 0.5mg/mL) 
1:1000 0.05% saponin 
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Anti-iNOS/NOS II rabbit polyclonal antibody (Merck 
Millipore, ABN26) 
1:100  







Table 8. Secondary antibodies and dyes used in ICC. 
Antibody / dye Dilution 
DyLight 649, 594 or 488-labeled Lacopersicon esculentum (tomato) lectin 
(Vector Laboratories DL-1178, 1177 or 1174) (1mg/mL) 
1:200 
(5µg/mL) 
Alexa Fluor® 647 AffiniPure donkey anti-rat IgG (H+L) (Jackson 
ImmunoResearch, 712-605-150) 
1:750 
Goat anti-rat IgG (H+L) cross-adsorbed secondary antibody, Alexa Fluor 
555 (Thermo Fisher Scientific, A-21434) 
1:750 
Goat anti-rabbit IgG (H+L) cross-adsorbed secondary antibody, Alexa 






The fluorescent images of spinal cord lesions were acquired using the Leica DMI6000 
widefield microscope using the 20× objective as tile scans (Figure 1-Figure 3). The 
images of ICC were acquired using the Leica DMI6000 widefield microscope using the 
20× objective (Figure 4; Figure 7C-F; Figure S1A and B), or the Leica SP5 confocal 
microscope using the 20× objective (Figure S1C) or the 63× oil objective (tile scans and 
Figure 7 z-stack images). The images of OHSC were acquired using the Leica SP5 
confocal microscope using the 20× objective as tile scans of z-stacks (Figure 13-Figure 
15). Images were taken at least 10 µm from the surface of the slices. The images of brain 
sections were acquired using the Leica SP8 confocal microscope using the 20× objective 
as tile scans (Figure 16). 
 
The bright-field images of LFB(-PAS) stain of spinal cord sections were acquired as tile 
scans using the Zeiss Axiophot microscope, the Olympus BX61VS light microscope, or 
the Zeiss Axio Imager M2 using the 20× objective. 
 
The bright-field images of semithin sections were acquired as tile scans using the Leica 







The images were analyzed using the software Fiji (Schindelin et al., 2012). Automated cell 
counting and measurement were conducted using CellProfiler (Carpenter et al., 2006). In 
CellProfiler, the nuclei were identified as primary objects based on the staining with DAPI 
or Hoechst 33342, according to the user-defined parameters such as thresholding 
method, threshold, and the diameter of objects and so on. Based on the nuclei, the cells 
were identified as secondary objects based on the staining for a cytoplasmic epitope or 
lectin stain. The staining for transcription factors such as OLIG2 was also used to identify 
primary objects. The objects were related and filtered, and the number of objects positive 
or negative for a marker was counted automatically. The regions of interest (ROI) tissue 
sections were masked on the images (Figure 1B-G, Figure 2, Figure 3 and Figure 16). 
Myelin debris and LysoTracker were also identified as primary objects and related to each 
other (Figure 6). The myelin debris (or LysoTracker) in each cell were identified by 
relating the primary objects to the cells and merging the objects that corresponded to the 
same cell (Figure 4 and Figure 6). The results were saved as images or exported to 
spreadsheets (in csv format). The numbers of remyelinated axons in the images of 
semithin sections were counted manually using the Fiji plugin “Cell Counter” (Figure 1H). 
The intensity of the bands in western blot was measured using Fiji (Figure 4F). 
 
The myelination in OHSC was analyzed as the proportion of the signal of the staining for 
both MBP and neurofilament heavy polypeptide (NF-H) among the signal of NF-H, using 
the ImageJ macros written by Dr. Ioannis Alexopoulos. To analyze the area of myelin 
sheaths, the z-stacks were projected by maximum intensity projection of the same number 
of optical slices. The projection was thresholded. The MBP+ fibers were selected for their 
relatively big size and small circularity using “Analyze Particles”, and the total area of 
MBP+ fibers in each projection was measured (Figure 13). To analyze the percentage 
volume of myelination, MBP and NF-H signals were identified by thresholding the z-
stacks. The voxels occupied by both MBP and NF-H were identified from the thresholded 
z-stacks using the image calculator (Figure 15). The myelination index was calculated 








The data were plotted and statistical tests were performed using the software Graphpad 
Prism (Figure 1, Figure 2, Figure 3, Figure 4G, Figure 13, Figure 15 and Figure 16). 
The csv spreadsheets containing the data of individual cells were analyzed using R and 




Laser microdissection for RNA-seq samples 
For RNA samples, all tools were cleaned and sprayed with RNaseZAP™ (Sigma, R2020). 
The mice were anesthetized in a CO2 chamber and euthanized by decapitation. The 
segment of spinal cord that contained lesions was dissected out, embedded in O.C.T. in a 
mold and flash-frozen in liquid nitrogen. The spinal cords were stored in a box with 
desiccant (Aldrich, Z163570-100EA) at the -80 °C. 
 
The spinal cords were placed in the cryostat for at least 30 min to equilibrate to -20 °C. 
Coronal sections were cut at a thickness of 16 µm and mounted onto pre-cooled 
MembraneSlide 1.0 PEN (D) Zeiss (Fisher Scientific, 415190-9041-000). O.C.T. was 
trimmed as much as possible. The bottom of the tissue block was trimmed to be parallel to 
the blade. If there were cracks in the O.C.T. of the sections, the temperature was raised to 
-19 or -18 °C. Several sections were cut and laid on the metal stage. The backside of the 
slide was warmed with fingers (wearing gloves) to warm the region for placing the 
sections. Then, the frozen sections were transferred to the slide by touching the warmed 
region. The slides with sections were dried in the cryostat for 10 min at -20 °C. After 
cryosectioning of the tissue block, the exposed tissue was covered with a drop of O.C.T. 
The tissue was wrapped in aluminum foil and stored with desiccant at -80 °C. The ethanol 
solutions for fixation and dehydration were prepared from ethanol for molecular biology 
containing molecular sieves (Carl Roth, 2405886) once the bottle was opened (to ensure 
that the ethanol did not get diluted by moisture) and nuclease-free water. Fresh 100% 
ethanol was used. The solutions were pre-cooled at -20 °C and re-used for no more than 
one week. Under the fume hood for RNA, the sections were fixed and dehydrated in 70% 
ethanol for 30 sec, 95% ethanol for 30 sec, and then twice in 100% ethanol for 1 min 
each. The slides were air-dried for 10 min. The dried slides were used for laser 
microdissection, or stored in a 50-mL conical tube with desiccant at -80 °C for up to 1 




When the slides were taken out of the -80 °C freezer for laser microdissection, the slides 
were dehydrated by passing them through the same series of -20 °C ethanol solutions, 
air-dried and kept in a closed conical tube with desiccant at RT. The 0.5-mL Axygen PCR 
tubes with adhesive caps (VWR, 732-0675) were used to collect dissected tissue on the 
Leica DM6000 B laser microdissection microscope (Leica Microsystems). Microdissection 
was carried out using the 10× objective, laser power 33, speed 8, current 100% and pulse 
frequency 146. The laser was calibrated on the section before microdissection. From each 
spinal cord, 20-45 pieces of lesions were collected in the cap of a PCR tube. The 
dissected tissue was checked under a stereoscope. Under the hood for RNA, 10 µL of 2-
mercaptoethanol (β-ME) (Sigma, 63689-25ML-F) was added to 1 mL of Buffer RLT 
(RNeasy Micro Kit (50), Qiagen, 74004). 350 µL of Buffer RLT containing β-ME was 
added to the tube. The cap was closed and incubated upside-down for 30 min at RT. After 
lysis, the tube was centrifuged for 5 min at 3000 ×g. The samples for RNA-seq were 
stored at -80 °C. 
 
 
Transcriptomics of demyelinated lesions 
cDNA library preparation and next-generation sequencing were performed in collaboration 
with the Laboratory of Prof. Dr. Moritz Rossner. Differential gene expression analysis and 
pathway analysis of the transcriptomic data were done by Nirmal Raman Kannaiyan. 
 
 
Proteomics and pathway analysis of cultured microglia 
For secretome analysis, microglia isolated by MACS from WT and Myd88-/- mouse pups 
were seeded in 6-well plates and cultivated in DMEM/FCS/L929 medium for 5 days until 
the cells were confluent. The microglia cultures were washed twice with warm 
DMEM/pyruvate medium and incubated with serum-free TCC medium for 3 h. The cells 
were treated with 30 µg/mL myelin debris (or HEPES control) in 1 mL of TCC medium for 
4 h, washed three times with warm PBS, and incubated with the DMEM for secretome 
analysis for 16 h (Table 1). The supernatant was passed through 0.22-µm filters and 




The cell lysate samples of microglia for the proteomic data included in this dissertation 
were prepared as follows. Microglia isolated by MACS from WT and Myd88-/- mouse pups 
were seeded at a density of 1×106 cells per 60-mm dish in DMEM/FCS/L929 medium. 
After 2 DIV, microglia were washed with warm DMEM/ pyruvate medium and treated with 
20 µg/mL myelin debris (or HEPES control) in 2 mL of TIC medium for 4 h. After 
treatment, the cells were washed with DMEM/ pyruvate medium, and incubated with 4 mL 
of DMEM containing 0.2% BSA for 16 h. The cells in each dish were washed with 2 mL of 
cold PBS on ice, and lysed with 200 µL of cell lysis buffer (Cell Signaling Technology, 
9803) containing 1 mM PMSF for 5 min on ice. The cells were detached using cell 
scapers, collected and stored at -80 °C. The samples were prepared in triplicates or 
quadruplicates. 
 
The mass spectrometry label-free quantification (LFQ) was performed in collaboration with 
the Laboratory of Prof. Dr. Stefan Lichtenthaler. The proteomic analysis using MaxQuant 
and Ingenuity Pathway Analysis were conducted by Dr. Stephan Müller. The comparisons 
of the following groups were analyzed: 
Comparison Label Ingenuity Pathway Analysis 
Myelin_WT vs. control_WT MY_WT/CON_WT Yes 
Myelin_Myd88-/- vs. control_Myd88-/- MY_KO/CON_KO Yes 
Myelin_ Myd88-/- vs. myelin_WT MY_KO/MY_WT Yes 
Control_ Myd88-/- vs. control_WT CON_KO/CON_WT - 
The genes that fulfilled the criteria | log2(LFQ ratio) | > 0.5 and p-value < 0.05 were 
considered as differentially expressed. The genes identified in the differential gene 
expression analysis were selected from the intersection of the comparisons “Myelin_WT 
vs. control_WT” and “Myelin_ Myd88-/- vs. myelin_WT” (Figure 9). The datasets of genes 
for which the p-value could be calculated were uploaded to the Ingenuity Pathway 
Analysis and selected for the cutoff mentioned above. For the analysis using the gene 
ontology enrichment analysis and visualization tool (GOrilla), two unranked lists – one of 
differentially expressed genes, and the other background list of the genes with a numeric 





Remyelination was impaired in the spinal cord of Myd88-/- mice 
The numbers of oligodendrocytes were analyzed in the demyelinated lesions at 7 and 21 
days post-injection (DPI). The lesions were identified by the lack of luxol fast blue (LFB) 
stain in the white matter. The lesions were filled with immune cells at 7 DPI and appeared 
pink due to the periodic acid-Schiff (PAS) stain (Figure 1A). The nuclei of oligodendrocyte 
progenitor cells (OPCs) were identified by the co-labeling of the transcription factors NKX-
2.2 and OLIG2 (Figure 1B). Myelinating oligodendrocytes expressed the marker BCAS1 
in their cytoplasm (Figure 1C). Mature oligodendrocytes expressed the transcription factor 
OLIG2 and the cytosolic marker APC (CC-1) (Figure 1D). The lesions of wild-type (WT) 
mice had a high number of OPCs at 7 DPI, which was decreased at 21 DPI. In contrast, 
the number of OPCs was low in the lesions of Myd88-/- mice at 7 DPI (Figure 1E). 
Consistently, the lesions of WT mice had many myelinating oligodendrocytes at 7 DPI but 
not a 21 DPI, but the increase in myelinating oligodendrocytes at 7 DPI was not observed 
in the lesions of Myd88-/- mice (Figure 1F). Mature oligodendrocytes were present in high 
numbers in the lesions of WT mice at 21 DPI, but the lesions of Myd88-/- mice were 
deficient in mature oligodendrocytes (Figure 1G). 
 
Remyelination was examined in the semithin sections of the spinal cord lesions at 21 DPI. 
Myelin was stained by methylene blue-azure II (Figure 1K). Regenerated myelin in the 
lesions was also stained but thinner than the myelin in normal white matter (Figure 1I and 
J). While the lesions of WT mice had a variable density of remyelinated axons, the lesions 
of Myd88-/- mice had very few remyelinated axons at 21 DPI (Figure 1H). Therefore, 
remyelination was defective in Myd88-/- mice. 
 
 
Figure 1. Remyelination was defective in the spinal cord of Myd88-/- mice. 
(A) Demyelinated lesions were identified by LFB-PAS stain. Oligodendrocytes at various 
developmental stages were analyzed in lesions. (B) OPCs express NKX-2.2 (magenta) and OLIG2 
(green). (C) Myelinating oligodendrocytes express BCAS1 (green). (D) Mature oligodendrocytes 
express APC (CC-1) (magenta) and OLIG2 (green). (E) Decreased cell density of OPCs in the 
lesions of Myd88-/- mice at 7 days post-injection (DPI). Unpaired t-test with FDR correction. (F) Few 
myelinating oligodendrocytes in the lesions of Myd88-/- mice at 7 DPI. Welch’s t-test. (G) 
Decreased number of mature oligodendrocytes in the lesions of Myd88-/- mice at 21 DPI. Unpaired 




(Figure 1 continued) 
(H) Impaired remyelination in the lesions of Myd88-/- mice at 21 DPI quantified by the density of 
remyelinated axons in semi-thin sections. Welch’s t-test (error bars: SD; n = 4-6 lesions). Lesions in 
(I) Myd88-/- and (J) WT mice. Remyelinated axons are wrapped by thin myelin (arrow heads). (K) 
Normal white matter is full of axons wrapped by thick myelin. (Images of semi-thin sections: 





Microglia / macrophages were recruited to demyelinated lesions 
The cell density of microglia / macrophages was analyzed in the core of the lesions at 
various time points. The cells expressing the general microglia / macrophage marker IBA1 
were recruited to the lesions of both Myd88-/- and WT mice. The density of IBA1+ cells 
peaked at 7 DPI and decreased afterwards. At 14 DPI, more IBA1+ cells remained in the 
lesions of Myd88-/- mice (Figure 2A and B). The FluoroMyelin Green stain inside IBA1+ 
cells showed that more myelin lipids accumulated in microglia / macrophages in the 
lesions of Myd88-/- than WT mice at 14 DPI (Figure 2A and C). On the other hand, IBA1+ 
cells contained similar amounts of myelin basic protein (MBP) in the lesions of Myd88-/- 
than WT mice at all the time points analyzed (Figure 2D). 
 
 
Figure 2. Microglia / macrophages containing myelin lipids remained in the lesions of Myd88-/- mice 
at 14 DPI. (A) and (B) IBA1+ microglia / macrophages (magenta) were recruited to the lesions of 
both WT and Myd88-/- mice at 7 DPI, and the density of IBA1+ cells decreased afterwards. At 14 
DPI (A), the proportion of the volume occupied by IBA1+ cells in the lesions (devoid of FluoroMyelin 
Green stain) was higher in Myd88-/- than WT. Welch’s t-test. (Error bars: 95% CI; n = 4-9 lesions) 
(C) More myelin lipids accumulated in microglia / macrophages in the lesions of Myd88-/- mice at 14 
DPI, analyzed by the proportion of the volume occupied by both FluoroMyelin Green stain (green) 
and IBA1 (magenta) (co-localization, white) in the lesions. Welch’s t-test. (Error bars: 95% CI; n = 4 
or 5 lesions) (D) The amount of myelin basic protein (MBP) inside IBA1+ cells was similar in the 




Astrogliosis was not affected in demyelinated lesions of Myd88-/- mice 
At 7 DPI, GFAP-positive astrocytes were found around the demyelinated lesions, which 
were full of microglia / macrophages. Some astrocytes seemed to be entering the lesions 
(Figure 3A). At 21 DPI, the lesions contained many astrocytes and reduced IBA1-positive 
cells (Figure 3B). The density of GFAP-positive cells in the lesions of WT and Myd88-/- 
mice were similar at both 7 and 21 DPI (Figure 3C). 
 
 
Figure 3. Astrocytes surrounded demyelinated lesions at 7 DPI and were in the lesions at 21 DPI. 
(A) At 7 DPI, the lesion core was devoid of GFAP+ astrocytes (green) and full of IBA1+ microglia / 
macrophages (magenta). (B) At 21 DPI, astrocytes reached the lesions, whereas microglia / 
macrophages left the lesions. (C) The cell density of astrocytes in the lesion core of Myd88-/- and 





Myelin debris was taken up faster and in larger amounts than non-myelin 
membrane by cultured microglia 
Upon demyelination or the damage to other membranous structures in the CNS, microglia 
respond by internalizing damaged membrane, usually by phagocytosis. To examine the 
specificity of this response to the type of damage, the phagocytosis of purified myelin 
debris and non-myelin membrane by cultured microglia was analyzed. Microglia were 
shaken off WT mixed glial cultures and cultured overnight in DMEM containing 20% L929 
cell-conditioned medium, 10% FCS, 1 mM sodium pyruvate and penicillin/streptomycin. 
The cells were washed with DMEM containing 1% BSA and 1 mM sodium pyruvate 
(DMEM/BSA medium), and treated with PKH67-labeled myelin or non-myelin fraction at a 
concentration of 1, 10 or 30 µg/mL in DMEM/BSA medium for 1, 2, 4 or 16 h. Microglia 
phagocytosed myelin (Figure 4A) and non-myelin fraction (Figure 4B) in vitro, but there 
was more myelin than non-myelin fraction inside the cells at each time point. The amount 
of labeled membrane in each cell was quantified by the integrated intensity of the 
fluorescence emitted by PKH67 that was localized within the cell stained by lectin. The 
violin plot of the intensity in each microglial cell (in log2 scale) showed the diversity in the 
amount of membrane in each cell (Figure 4E). The mean and 95% confidence interval 
(CI) of the intensity in each cell indicated that more myelin than non-myelin fraction was 
phagocytosed by cultured microglia with a faster kinetics (Figure 4D). 
 
The western blot of myelin and non-myelin fraction for MBP showed that the non-myelin 
fraction had little myelin proteins (Figure 4F). The quantification of the integrated intensity 
of MBP bands suggested that the non-myelin fraction contained around 2.311% (mean of 
0.943% and 3.678%) myelin proteins. 
 
Since myelin has higher lipid content than other membrane, and PKH67 labels lipids, we 
asked whether the larger apparent amount of myelin in microglia was due to the labeling 
or the differential lipid content of myelin and non-myelin membrane. The ratio of mean 
integrated intensity of myelin to non-myelin fraction was higher than the ratio of 
fluorescence measured from PKH67-labeled myelin to non-myelin fraction (Figure 4G), 
suggesting that the labeling was not the main factor in the observed difference in the 
amount of uptake. The ratio of the amount of myelin to non-myelin in cells was also higher 
than the theoretical ratio of lipid content of myelin to non-myelin membrane 70% : 50%. 





Figure 4. Cultured microglia internalized more myelin debris than non-myelin membrane. 
WT microglia (magenta) were treated with (A) purified myelin or (B) non-myelin fraction labeled 
with PKH67 (green) at a protein concentration of 1, 10 or 30 µg/mL or (C) PBS control for 1, 2, 4 or 
16 h. The amount of myelin in each cell was measured by the integrated intensity of PKH67: (D) 
mean and 95% CI; (E) violin plot of intensity in log2 scale (1 experiment, 2 coverslips per condition, 
4 views per coverslip). (F) The purity of non-myelin fraction was checked by western blot for MBP. 
(G) The higher integrated intensity of PKH67 measured in the cells treated with myelin than in 
those treated with non-myelin fraction was not due to differential labeling with PKH67. The ratio of 
mean integrated intensity of myelin to non-myelin fraction per cell (at each concentration and time 
point) was higher than the ratio of theoretical lipid composition of myelin (70%) to other membrane 
(50%), which was higher than the ratio of measured fluorescence intensity of PKH67-labeled 




The amount of myelin debris in cultured microglia 
WT and Myd88-/- microglial cell cultures (MACS) were incubated with serum-free TCC 
medium overnight, and treated with PKH67-labeled myelin at the same time for the 
comparison of the amount of myelin uptake in each experiment. 
 
For a short exposure to myelin debris, microglia were treated with 30 µg/mL myelin-
PKH67, and chased in TCC medium for 15 or 30 (Figure 5A and B). The membrane of 
the fixed cells was stained with lectin. The images were acquired as z-stacks of 6 optical 
slices (0.5 µm apart) using the confocal microscope. Maximum intensity projection images 
of the z-stacks were analyzed using CellProfiler. The amount of myelin in each cell was 
quantified by measuring the integrated intensity of the thresholded images of the PKH67 
channel that was enclosed by the cells. The amount of myelin debris was similar in the 
cells of different genotypes 15 min after the treatment with myelin debris. The remaining 
myelin debris attached to the coverslips got phagocytosed by microglia, and therefore 
more myelin was found in the cells 30 min after treatment than 15 min after treatment. WT 
microglia phagocytosed more myelin debris on average than Myd88-/- microglia 30 min 
after treatment (Figure 5A and B). 
 
After microglia were treated with 8 µg/mL myelin-PKH67 for 2 h, most WT microglia had 
phagocytosed myelin. In this scenario, WT microglia contained slightly more myelin debris 





Figure 5. The amount of PKH67-labeled myelin in cultured microglia measured by the integrated 
intensity of PKH67 in each cell. 
In (A) and (B), microglia were treated with 30 µg/mL myelin debris for 15 min, and incubated with 
medium for 15 or 30 min. In (C) and (D), microglia were treated with 8 µg/mL myelin debris for 2 h. 




Maturation of phagosomes containing myelin debris in cultured microglia 
After overnight incubation with the serum-free TCC medium and the pre-labeling of cell 
membrane and nuclei, microglia cultures (MACS) were treated with 30 µg/mL PKH67-
labeled myelin together with LysoTracker for 15 min, and afterwards incubated with TCC 
medium for 60 min. Both WT and Myd88-/- microglia phagocytosed myelin debris. Acidified 
organelles, endolysosomes or lysosomes, formed in the cells and fused with the 
phagosomes containing myelin debris (Figure 6A and B). 60 min after myelin treatment, 
the average number of myelin-positive phagosomes that had fused with LysoTracker-
positive organelles in each cell was higher in WT microglia than in Myd88-/- microglia 
(Figure 6C). The analysis of the area of myelin debris in LysoTracker-labelled organelles 
also showed that there was less phagosome fusion in Myd88-/- microglia than in WT 





Figure 6. Less fusion of phagosomes containing myelin debris with (endo)lysosomes was 
observed in cultured Myd88-/- than WT microglia 60 min after the treatment with myelin debris. 
(A) and (B) In microglia, myelin+ phagosomes that had fused with LysoTracker (white arrowhead) 
and myelin+ phagosomes that had not fused with LysoTracker (open arrowhead) were observed. 
(C) The number of myelin+ phagosomes that had fused with LysoTracker+ acidified organelles in 
each cell. (D) The area of the overlap between myelin debris and LysoTracker in each cell. (C) and 
(D) show the data pooled from n = 3 independent experiments. 
 
 
After microglia were treated with 30 µg/mL myelin for 15 min and incubated with medium 
for 15min (Figure 7A), the localization of LAMP-2 was altered compared with the control 
(Figure 7B). The integrated intensity of LAMP-2 immunofluorescence in each cell was 
high in WT and Myd88-/- microglia 15 min after the exposure to myelin debris, and 
decreased 30 min after treatment. This suggests that the total expression of LAMP-2 
protein was increased shortly after the phagocytosis of myelin debris (Figure 7C and D). 
The mean intensity of LAMP-2 in the perinuclear region decreased more in Myd88-/- than 
WT microglia from 15 to 30 min after myelin treatment (Figure 7E and F). The changes in 
intensity and localization of LAMP-2 suggest the assembly of LAMP-2 proteins in 
endolysosomes, which occurred prior to the phagosome maturation observed 60 min after 





Figure 7. LAMP-2 proteins were assembled in the membrane of endolysosomes containing myelin 
debris in cultured microglia. 
(A) Microglia were treated with 30 µg/mL myelin-PKH67 (green) in TCC medium for 15 min, and 
incubated with TCC medium for 15 min; (B) control cells (imaged acquired using the 63× oil 
objective of a confocal microscope). The localization and fluorescence intensity of ICC for LAMP-2 
(magenta) changed after the exposure to myelin debris. (C) and (D) The integrated intensity of 
LAMP-2 per cell was high 15 min after myelin treatment and decreased 30 min after treatment. (E) 
and (F) The mean intensity of LAMP-2 in the perinuclear region decreased from 15 min to 30 min 
after myelin treatment in Myd88-/- microglia, but the decrease was smaller in WT microglia. (C) and 
(E) mean and 95% CI; (D) and (F) violin plot (The quantification of fluorescence intensity: 1 
experiment, 2-4 coverslips per condition, 6 views per coverslip; images acquired using the 20× 





Proteomic analysis of cultured microglia after exposure to myelin debris 
To identify the molecules secreted by microglia after myelin damage, which regulate the 
responses of OPCs / oligodendrocytes for remyelination, the supernatant of microglia 
cultures was analyzed by mass spectrometry. WT and Myd88-/- microglial cell cultures 
prepared by MACS were treated with 30 µg/mL myelin debris (or HEPES control) in TCC 
medium for 4 h, and incubated with DMEM for 16 h. The supernatant was collected for 
proteomic analysis. Label-free quantification (LFQ) identified around 2000 proteins in each 
supernatant sample, among which around 10.13% are annotated as secreted proteins in 
the Uniprot database. In each comparison of two groups, the relative amount of the 
proteins identified in the supernatant and the p-value were visualized in volcano plots 
(Figure 8). The amounts of a protein that fulfilled the criteria | log2(LFQ ratio) | > 0.5 and 





Figure 8. Volcano plots show the relative amount of proteins in the supernatant of microglial cell 
cultures. 
WT and Myd88-/- microglia were treated with myelin or control for 4 h in serum-free medium TCC 
medium, and the supernatant was collected in DMEM for 16 h. (A) WT microglia treated with 
myelin vs. control. (B) Myd88-/- microglia treated with myelin vs. control. (C) Myd88-/- microglia 
treated with myelin vs. WT microglia treated with myelin. (D) Myd88-/- microglia control vs. WT 
microglia control. The proteins with a p-value < 0.05 are shown in red, and p-value > 0.05 are 
shown in blue. The significant proteins after permutation-based FDR correction are above the 




To select the candidate proteins that were secreted by WT microglia after the exposure to 
myelin debris but were not secreted by Myd88-/- microglia, the differential proteins were 
selected from the intersection of the two comparisons: myelin_WT / control_WT and 
myelin_Myd88-/- / myelin_WT (Figure 9). The differentially expressed or secreted proteins 
identified by comparing WT microglia after myelin treatment and control were likely to 
function in the response of microglia to myelin damage. Among these genes, the ones 
that were expressed or secreted at different levels by Myd88-/- and WT microglia after 
myelin treatment might help to explain the altered response of Myd88-/- microglia that led 
to impaired remyelination in vivo. The proteins identified in both comparisons of the 
supernatant of myelin_WT / control_WT and myelin_Myd88-/- / myelin_WT are listed in 
Appendix 1. For instance, the abundance of growth/differentiation factor 15 (GDF-15) in 
the supernatant of WT microglia after myelin treatment was 2.87 fold of control, but its 
amount in the supernatant of Myd88-/- microglia after myelin treatment was 0.629 fold of 
that after WT microglia were exposed to myelin debris. GDF-15 is a member of the TGF-β 
superfamily. It is a cytokine and growth factor (Uniprot) that has a neurotrophic role 
(Machado et al., 2016; Strelau et al., 2000). Another protein, metalloproteinase inhibitor 1 
(TIMP-1), was increased in the supernatant of myelin-treated WT microglia (2.70 fold of 
WT control), but the amount in the supernatant of Myd88-/- microglia after the exposure to 
myelin debris was 0.638 fold of the myelin-treated WT microglia. While TIMP-1 inhibits 
metalloproteinases, it also functions as a growth factor and regulates integrin signaling 
(Uniprot). In addition, two proteins involved in the inflammatory response of phagocytosis, 
collectin-12 (CL-12) and annexin A5, were identified. CL-12 was more abundant in the 
supernatant of WT microglia after myelin treatment than control, but less abundant in the 
supernatant of myelin-treated Myd88-/- microglia than WT microglia. In contrast, annexin 
A5 was decreased in the supernatant of WT microglia after the exposure to myelin than 






Figure 9. Method to identify the differentially expressed genes from two comparisons. 
Set A includes the differentially expressed genes in the comparison myelin_WT/control_WT, which 
might be relevant to the exposure to myelin debris. Set B includes the differentially expressed 
genes in the comparison myelin_Myd88-/-/myelin_WT, which were relevant to the genotype. The 
intersection of A and B includes the genes that were differentially expressed in cultured Myd88-/- 
and WT microglia that might be relevant to myelin treatment. 
 
The proteomic data of microglial cell lysate were analyzed in terms of differential gene 
expression and pathway analysis. In this experiment, WT and Myd88-/- microglial cell 
cultures prepared by MACS were treated with 20 µg/mL myelin debris (or HEPES control) 
for 4 h and incubated with DMEM containing 0.2% BSA for 16 h. Pairwise differential gene 
expression analyses were visualized as volcano plots (Figure 10). The comparison 
between control Myd88-/- and WT microglia did not identify significant genes, which 
suggests that the baseline protein expression profiles of Myd88-/- and WT microglia were 
similar (Figure 10D). After the exposure to myelin debris, a characteristic protein 
expression profile was induced in WT microglia (Figure 10A). Myelin debris also activated 
the expression of a set of proteins by Myd88-/- microglia (Figure 10B), but the myelin-
induced protein expression profile of Myd88-/- microglia was distinct from that of WT 





Figure 10. Differential gene expression analyses of the proteomic data of microglial cell lysate. 
WT and Myd88-/- microglial cell cultures were treated with myelin or control for 4 h in serum-free 
TIC medium and incubated with DMEM containing 0.2% BSA for 16 h. (A) WT microglia treated 
with myelin vs. control. (B) Myd88-/- microglia treated with myelin vs. control. (C) Myd88-/- microglia 
treated with myelin vs. WT microglia treated with myelin. (D) Myd88-/- microglia control vs. WT 
microglia control. Myd88-/- microglia have similar protein expression profile to WT microglia in vitro. 
The significant genes after FDR correction are above the dashed curves. (n = 3 or 4 samples of 
each condition) 
 
The 10 differentially expressed genes identified in both the comparisons myelin_WT / 
control_WT and myelin_Myd88-/- / myelin_WT (Table 9) were classified into 3 groups: (1) 
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the proteins that were decreased in WT microglia upon myelin treatment, but the 
expression in Myd88-/- microglia was higher; (2) the proteins that were increased in WT 
microglia after the exposure to myelin, but were decreased in Myd88-/- microglia; and (3) 
the proteins that were decreased in WT microglia after myelin treatment, and were 
decreased even more in Myd88-/- microglia. 
 
Table 9. Differentially expressed genes identified to be significant in the proteomic analysis of 
microglial cell lysate in both comparisons myelin_Myd88-/- / myelin_WT and myelin_WT / control 
WT (log2(expression ratio) < -0.5 or > 0.5, and p-value < 0.05). 
(1) Pald1, Camk1d and Tbck were decreased in myelin_WT / control WT but increased in 
myelin_Myd88-/- / myelin_WT (blue shading). 
(2) Pin4, Eif2s3y, Wdr92, Parp12 and Tmem106a were increased in myelin_WT / control WT but 
decreased in myelin_Myd88-/-/ myelin_WT (orange shading). 
(3) Csf1r and Hpgd were decreased in myelin_WT / control WT and decreased even more in 
myelin_Myd88-/- / myelin_WT (white shading). 










Paladin Pald1 0.84 6.74E-03 + -0.95 2.41E-02 + 
Calcium/calmodulin-dependent 
protein kinase type 1D 
Camk1d 0.52 7.53E-03  -0.58 3.11E-02  
TBC domain-containing protein 
kinase-like protein 
Tbck 0.66 1.06E-02 + -0.53 4.40E-03 + 
Peptidyl-prolyl cis-trans 
isomerase NIMA-interacting 4 
Pin4 -0.60 4.91E-03 + 1.14 8.05E-04 + 
Eukaryotic translation initiation 
factor 2 subunit 3, Y-linked 
Eif2s3y -1.09 6.12E-03 + 0.95 2.50E-02 + 
WD repeat-containing protein 
92 
Wdr92 -0.72 4.31E-02  0.63 3.40E-02  
Poly [ADP-ribose] polymerase 
12 
Parp12 -0.51 3.71E-02  0.54 2.37E-02  
Transmembrane protein 106A Tmem106a -0.68 4.12E-05 + 0.53 2.02E-02  
Macrophage colony-stimulating 
factor 1 receptor 
Csf1r -0.86 3.43E-02  -1.02 1.74E-04 + 
15-hydroxyprostaglandin 
dehydrogenase [NAD(+)] 




The relative expression level of markers for microglia activation and lysosomal function in 
WT and Myd88-/- microglia after myelin treatment are listed in Table 10. The expression of 
APOE was significantly increased in WT microglia upon the exposure to myelin debris. 
Galectin-3 was upregulated to a similar degree in WT and Myd88-/- microglia. TREM2 was 
slightly upregulated by myelin in WT microglia, but the expression was slightly lower in 
Myd88-/- microglia. The expression of CSF1R was decreased upon myelin treatment and 
decreased even more in Myd88-/- microglia. Myd88-/- microglia expressed significantly 
higher level of arginase-1 than WT microglia after myelin treatment, but the induction of 
arginase-1 by myelin in WT microglia was negligible. LAMP-2 expression level was mildly 
increased in WT microglia after myelin treatment, but the expression was lower in Myd88-/- 
microglia. The expression of IBA1, CD68 or LAMP-1 was not changed much. The Nos2 
gene (encoding iNOS) was not identified by differential gene expression analysis. 
 
Table 10. Selected markers for microglia activation and lysosomal function identified in the 
proteomic analysis of microglial cell lysate. 
A differentially expressed gene in a comparison should meet the criteria log2(expression ratio)<-0.5 
or >0.5, and p-value<0.05 (marked red). Significant genes after FDR are marked with “+”. 













Aif1 -0.56 1.21E-01  -0.13 7.36E-01  
Galectin-3 Lgals3 0.06 4.61E-01  0.42 1.69E-02  
Macrophage 
colony-stimulating 
factor 1 receptor 
Csf1r -0.86 3.43E-02  -1.02 1.74E-04 + 
Arginase-1 Arg1 0.64 6.93E-03 + 0.25 2.47E-01  
Apolipoprotein E Apoe -0.15 1.98E-01  1.13 5.84E-04 + 
Triggering receptor 
expressed on 
myeloid cells 2 
Trem2 -0.21 1.40E-02  0.41 2.34E-03 + 












Lamp1 -0.15 4.12E-02  0.13 3.42E-02  
 
 
To identify the molecules and pathways that are involved in the microglia response to 
myelin debris, pathway analyses were performed for the differentially expressed genes 
identified in the comparisons of cell lysate “myelin_WT / control_WT”, “myelin_Myd88-/- / 
control_Myd88-/-” and “myelin_Myd88-/- / myelin_WT” using Ingenuity Pathway Analysis 
(IPA) and GOrilla. IPA identified comprehensive lists of predicted upstream regulators, 
mechanistic networks and causal networks. Among the common upstream regulators that 
were predicted from the comparisons “myelin_WT / control_WT” and “myelin_Myd88-/- / 
myelin_WT” (Table 11), IFN-γ-regulated pathways were inhibited (z-score < 0) in 
myelin_Myd88-/- vs. myelin_WT but activated (z-score > 0) in myelin_WT vs. control_WT. 
The target molecules that were predicted to be regulated by IFN-γ activation in WT cells 
upon the exposure to myelin debris are shown in Figure 11A. By comparing Myd88-/- 
microglia after treatment with WT microglia after treatment, IFN-γ inhibition regulated the 




Table 11. Selected upstream regulators predicted in both comparisons myelin_Myd88-/-/myelin_WT 
and myelin_WT/control WT by Ingenuity Pathway Analysis of the proteome of microglial cell lysate. 
The upstream regulators that were activated in myelin_WT / control WT but inhibited in 
myelin_Myd88-/-/ myelin_WT are labeled with orange shading. 
The upstream regulators that were inhibited in myelin_WT / control WT but activated in 
myelin_Myd88-/- / myelin_WT are labeled with blue shading. 
The other upstream regulators that were regulated in the same direction in myelin_WT / control WT 
and in myelin_Myd88-/- / myelin_WT are labeled with white shading. 
Comparison Myelin_WT / control_WT Myelin_Myd88-/- / myelin_WT 
Upstream 
regulator 
















IFNG Cytokine - 0.579 1.58E-02 Inhibited -2.928 3.39E-09 
TNF Cytokine - 0.204 2.29E-04 - -0.48 9.32E-10 
60 
 
IL10 Cytokine - -0.713 4.30E-02 - 0.739 2.08E-03 
TGFB1 Growth factor - -0.62 3.01E-02 - 2.249 5.85E-04 
AGT Growth factor - -1.68 
 
2.00E-02 - -0.242 1.78E-02 
TLR4 Transmembrane 
receptor 
- -1.22 3.39E-02 Inhibited -1.872 1.21E-03 
ADRB Receptor (group) Activated 2.992 8.55E-06 - -0.283 1.75E-03 
MGEA5 Enzyme - -0.236 5.35E-04 Inhibited -2.91 7.65E-04 
IKBKB Kinase - 1.225 2.11E-02 - -1.418 9.49E-04 
Mek Kinase (group) - 0.065 3.35E-02 - 1.638 6.29E-04 
PPARA Ligand-dependent 
nuclear receptor 
Activated 1.723 3.66E-06 - -0.576 1.37E-02 
PPARD Ligand-dependent 
nuclear receptor 
- 0.53 1.83E-02 - -0.649 1.49E-02 
PPARGC1A Transcription 
regulator 
Activated 2.054 7.76E-03 - -0.361 3.62E-02 
NFkB 
(complex) 
Complex - -0.231 3.15E-02 - -0.504 1.91E-03 
JUN Transcription 
regulator 
- -0.172 4.88E-02 - 0.527 1.27E-02 
CREB1 Transcription 
regulator 
- 1.552 3.21E-07 - 0.758 1.51E-02 
STAT6 Transcription 
regulator 
- 0.742 1.72E-02 - 1.845 1.90E-05 
TP53 Transcription 
regulator 
Activated 1.979 6.79E-02 - 2.204 1.15E-03 
HMGA1 Transcription 
regulator 
- 0.447 2.30E-02 - 0.468 2.76E-03 
SIRT1 Transcription 
regulator 







Figure 11. IFN-γ was predicted by Ingenuity Pathway Analysis to be an upstream regulator 
(A) activated in cultured WT microglia after the exposure to myelin debris compared with control; 
(B) inhibited in cultured Myd88-/- microglia compared with WT microglia after the exposure to 
myelin debris. (C) Mechanistic network regulated by IFN-γ predicted in Myd88-/- microglia 
compared with WT microglia after the exposure to myelin debris. 
 
The pathway analysis of the genes that were differentially expressed in cell lysate 
predicted the pathways with gene enrichment using the GOrilla tool. The exposure to 
myelin debris induced the expression of genes enriched in lipid metabolic processes, 
lipoprotein particle organization, and lipid transport in WT microglia (Appendix 2A) 16 h 
after a 4 h of treatment with myelin debris. Myd88-/- microglia, compared with WT 
microglia, after the exposure to myelin debris expressed genes enriched in immune 
response, respiratory burst and phagocytosis (Appendix 2B). Myelin debris also led to the 
enrichment of genes in lipid metabolic processes in Myd88-/- microglia but was associated 
with a broader range of gene enrichment than the response of WT microglia (Appendix 





Transcriptomic analysis of demyelinated lesions 
To compare the gene expression profiles of microglia / macrophages in the demyelinated 
lesions of Myd88-/- and WT mice, the lesions were isolated when the number of microglia / 
macrophages was the highest (7 DPI). The transcriptomic analysis identified around 210 
differentially expressed genes that were statistically significant (| log2(ratio) | ≥ 2 and p-
value < 0.05). Some of these genes encode secreted proteins, including Ccl22 (a 
chemokine), Inhbb (TGF-β superfamily), Lif (an IL-6 family cytokine) and Pkdcc and so on. 
Other genes are annotated to have functions in signaling, metabolism, lipid processing, 
inflammation, adhesion, growth and survival, etc. 
 
 
Figure 12. Differential gene expression analysis of the transcriptomes of demyelinated lesions in 
Myd88-/- compared with WT mice. 






Assay for myelination in organotypic hippocampal slice culture (OHSC) 
The myelination assay was established in OHSC for testing the effects of molecules on 
oligodendrocyte differentiation and myelination. The treatments with 3,3’,5-triiodo-L-
thyronine (T3) for various time and at different concentrations were compared in OHSC 
and organotypic cerebellar slice culture (OCSC) (Hill et al., 2014). OHSC showed more 
increase of myelination in response to T3 than OCSC (data not shown), and thus the 
myelination assay was further optimized in OHSC. The OHSC treated with 80 ng/mL T3 
from 7 DIV for 5 days had increased myelination compared with the control slices (Figure 
13). The candidate molecules identified in proteomic and transcriptomic screens can be 
tested by the myelination assay in OHSC using T3 as a positive control. 
 
 
Figure 13. Myelination in organotypic hippocampal slice culture (OHSC). 
OHSC treated with 80 ng/mL T3 (B) had more myelin sheaths (green) compared with control (A). 
(Neurofilament 200, magenta) (C) Myelination was measured by the proportion of the area of the 
hippocampal slice that was occupied by MBP+ fibers. Unpaired, parametric t-test compared with 
the control (Error bars: 95% CI; n = 4-7 slices). 
 
 
Demyelination model by the injection of lysolecithin in OHSC 
Lysolecithin-induced demyelination model was established in OHSC for studying various 
cellular events of remyelination and for testing the effects of candidate molecules. The 
treatment with 0.5 mg/mL lysolecithin (in the medium and on top of the slices) for 24 h 
only induced demyelination on the surface, probably due to insufficient penetration of 
lysolecithin into the thick slices. The surface of the slices was mainly damaged by cutting 
during culture preparation, and no clear difference was observed between the surface of 
the slices treated with lysolecithin and those treated with PBS solvent control. Extended 
lysolecithin treatment affected the viability of the slice culture (data not shown). Therefore, 
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50 nL of 0.5 mg/mL lysolecithin was delivered into hippocampal slices by injection. 
Lysolecithin and PBS were labeled with PKH26, which visualized the injection site (Figure 
14A). In the slices injected with lysolecithin, the number of microglia increased in the 
vicinity of the injection site, and many microglia exhibited larger cell bodies and shorter 
processes. Myelin was disrupted by lysolecithin, forming the debris that was stained by 
the anti-MBP antibody. Myelin debris in microglia was observed (Figure 14B). In contrast, 
the injection of PBS left myelin mostly intact and did not alter the ramified morphology of 
microglia in OHSC (Figure 14C). Therefore, the injection of lysolecithin induced 
demyelination in OHSC. However, a lot of myelin debris still remained in lysolecithin-
injected slices 7 days post-injection (Figure 14D) and 14 DPI, and many fewer intact 
myelin sheaths were observed than in control slices (Figure 14E). 
 
 
Figure 14. Lysolecithin-induced focal demyelination in OHSC. 
After myelination ex vivo (13 DIV), OHSC slices were injected with lysolecithin or PBS labeled with 
PKH26. (A) PKH26 (yellow) identifies the injection site and the region where lysolecithin or PBS 
diffused to (2 DPI). At 4 DPI, (B) myelin (MBP, magenta) was disrupted and some myelin debris 
was inside microglia (IBA1, green) in the slices injected with lysolecithin, whereas (C) myelin was 
mostly intact in the slices injected with PBS control. After 7 DPI, (D) myelin debris (MBP, green) 
was still found in lysolecithin-injected slices, and not as many myelin sheaths were present as in 




Autoimmune demyelination model in OHSC 
Antibody and complement-mediated demyelination model was established in OHSC. After 
myelination for 13 DIV, OHSC was treated with 10 µg/mL anti-MOG Z2 antibody and 5% 
guinea pig complement for 72 h. MOG antibody and complement led to the disruption of 
myelin sheaths (Figure 15A), which did not occur in the slices treated with mouse IgG2aκ 
(isotype control) and complement at the same concentration (Figure 15B). The 
myelination index of the slices treated with Z2 antibody and complement was significantly 
decreased by around 51% compared with the control slices (Figure 15C). MOG antibody 
and complement induced demyelination in WT OHSC, but remyelination did not occur 7 
days post-treatment (DPT) (Figure 15E). Interestingly, most microglia exhibited ramified 
morphology after 72 h of treatment with Z2 antibody and complement (Figure 15D). After 
microglia had been depleted by clodronate, the treatment with Z2 antibody and 
complement did not cause demyelination in OHSC (Figure 15F). Furthermore, MOG 
antibody and complement-mediated demyelination was alleviated in Myd88-/- OHSC 
(Figure 15G). 
 
Figure 15. MOG antibody and complement induced demyelination in WT OHSC. 
(A) After 72 h of treatment with 10 µg/mL anti-MOG Z2 antibody and 5% guinea pig complement, 
the slices had fewer myelin sheaths (co-localization of MBP (green) and NF-H (magenta)) than (B) 
the slices treated with the isotype control (mIgG2aκ) and complement. (C) The myelination index 
(MBP+ NF-H+ / NF-H+ (%)) was calculated as the voxels occupied by the signals of both MBP and 
NF-H divided by the voxels occupied by the signals of NF-H. Welch’s t-test (Error bars: 95% CI; n = 
8-10 slices from 2 independent experiments. The data points were normalized to have the same 
mean myelination index of control slices.) (D) After WT OHSC was treated with Z2 antibody and 
complement for 72 h, microglia (IBA1, yellow) exhibited ramified morphology. (E) Remyelination did 
not occur 7 days after the treatment with Z2 antibody and complement (7 DPT). (F) After microglia 
were depleted from OHSC with clodronate, Z2 antibody and complement did not induce 
demyelination in WT OHSC lacking microglia. (G) Z2 antibody and complement did not induce 
significant demyelination in Myd88-/- OHSC. (Error bars: 95% CI. 7 DPT, clodronate treatment and 








Oligodendrocyte development in Myd88-knockout mice 
Since the increase in the number of OPCs in demyelinated lesions at 7 DPI was abolished 
in Myd88-/- mice, we asked whether MyD88 was required for oligodendrogenesis during 
development. The number of OPCs was analyzed in the corpus callosum (CC) of P7 
mice, because the density of OPCs is high in the CC of WT pups at this age (Figure 16A). 
Similar numbers of OPCs (Figure 16B and D) and oligodendrocyte-lineage cells (Figure 
16C) were found in the CC of P7 WT and Myd88-/- mice, indicating that MyD88 may be 
dispensable for OPC proliferation during development. 
 
 
Figure 16. The recruitment of OPCs to developing white matter in the corpus callosum (CC) of 
Myd88-/- mice was not affected. 
The numbers of oligodendrocytes and OPCs in the CC of postnatal day 7 Myd88-/- and WT mice 
were similar. (A) The nuclei of OPCs in CC were identified by the expression of both the 
transcription factors NKX-2.2 and OLIG2. (B) The cell density of OPCs in CC was similar. (C) The 
cell density of oligodendrocyte-lineage cells in CC was similar. (D) The proportion of OPCs among 






MyD88-dependent pathways are necessary for the recruitment of OPCs and 
remyelination 
To understand the roles of microglia – the main resident cells that mediate inflammatory 
response in the CNS – in remyelination, the lesions of Myd88-/- mice were analyzed after 
focal demyelination induced by the injection of lysolecithin in the spinal cord. Fewer OPCs 
and early myelinating oligodendrocytes were observed in the lesions of Myd88-/- than wild-
type (WT) mice at 7 days post-injection (DPI) (Figure 1E and F). Less recruitment of 
OPCs may be due to the lack of signals for proliferation and/or migration of OPCs. 
Consistently, the lesions of Myd88-/- mice had fewer mature oligodendrocytes and 
impaired remyelination at 21 DPI (Figure 1G and H). 
 
The Myd88 gene is predominantly expressed by microglia / macrophages (Brain RNA-
Seq), and therefore they are the main cell types affected by the knockout of Myd88 in the 
CNS. During the peak of inflammatory response (7 DPI), microglia / macrophages occupy 
demyelinated lesions at an extremely high density and exhibit amoeboid morphology. As 
inflammation is gradually resolved, microglia / macrophages leave the lesions (Cantuti-
Castelvetri et al., 2018). Similar density of microglia / macrophages was observed in the 
core of the lesions of Myd88-/- and WT mice at 7 and 21 DPI, but more IBA1+ cells 
remained in the lesions of Myd88-/- mice at 14 DPI (Figure 2A and B). At this timepoint, 
FluoroMyelin stain detected more myelin lipids accumulated in IBA1+ cells in the lesions of 
Myd88-/- mice (Figure 2A and C), whereas MBP inside IBA1+ cells were similar in the 
lesions of Myd88-/- and WT mice at 7, 14 and 21 DPI (Figure 2D). This suggests that 
microglia / macrophages in Myd88-/- mice were defective in degrading myelin lipids after 
they internalize damaged myelin in the lesions. Remyelination begins from the edge of the 
lesions, and astrocytes start to repopulate the lesions. Some microglia / macrophages, 
especially the foam cells containing lipid droplets, remain in the core of the lesions for a 
long time. The lesion core usually has delayed remyelination and can sometimes have 
necrosis. Since the density of inflammatory cells can be variable depending on the region 
of the lesion (unpublished observations by colleagues), microglia / macrophages should 
be analyzed near the edge as well as in the core of the lesion. Alternatively, all the 





The astrocytes in demyelinated lesions appeared similar in WT and Myd88-/- mice at the 
time points analyzed (Figure 3). GFAP is expressed by reactive astrocytes in general but 
cannot distinguish the specific activation phenotypes of astrocytes (Brahmachari et al., 
2006; Liddelow et al., 2017). Although astrocytes do not express much Myd88 mRNA 
(Brain RNA-Seq), they might secrete cytokines and growth factors in response to 
activated microglia (Hammond et al., 2014; Petkovic et al., 2016), which could be 
dependent on MyD88-mediated signaling. It was suggested that astrocytes become 
activated by IL-1 receptor (IL-1R)/MyD88 signaling and secrete pro-inflammatory 
cytokines and chemokines after spinal cord injury (Pineau et al., 2010). However, it was 
proposed that MyD88 does not mediate IL-1R signaling in mouse astrocytes, whereas the 
IL-1R signaling in human astrocytes is dependent on MyD88 or TRIF (Tarassishin et al., 
2014). Since no obvious phenotype was found in the astrocytes of Myd88-/- mice, the 
responses of astrocytes during remyelination were not analyzed in this study. 
 
Myd88-/- mice have reduced inflammatory response and defects in T cell proliferation, but 
the other aspects of the animals are similar to WT mice (Adachi et al., 1998). Toxin-
induced demyelination is independent of the actions of T cells (Kremer et al., 2016). 
Myd88-/- mice might lack regulatory T cells that promote oligodendrocyte differentiation 
during remyelination (Dombrowski et al., 2017). However, (1) microglia / macrophages 
were the predominant cell types in the lesions when the defective OPC recruitment was 
observed in Myd88-/- mice; and (2) whether oligodendrocyte differentiation was normal in 
the lesions of Myd88-/- mice was not conclusive due to fewer OPCs at an earlier time point 
(Figure 1E-G). Therefore, Myd88-/- microglia were further studied to identify the cause of 
impaired OPC recruitment and remyelination. 
 
 
MyD88-deficient microglia have impaired phagosome maturation after the 
phagocytosis of myelin debris 
Microglia maintain the homeostasis by clearing tissue debris and dead cells in the CNS 
(Hammond et al., 2018), and they are probably the first cells to detect the damage of 
myelin and phagocytose myelin debris (Franklin and Ffrench-Constant, 2017). To 
understand the mechanisms of microglial response to demyelination, the phagocytosis of 
myelin debris, phagosome maturation and the clearance of myelin debris by WT and 
Myd88-/- microglia were compared in cell culture. Microglia isolated by MACS is preferred 
to the shake of mixed glial cultures, because the morphology of microglia in the MACS 
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culture is more diverse and similar to the ramified morphology of homeostatic microglia in 
vivo, whereas most cells in the culture prepared by shakes have amoeboid morphology of 
activated microglia. Serum in the growth medium activates microglia and enhances 
phagocytosis. When the microglia isolated by MACS were cultivated directly in defined, 
serum-free TIC medium (Bohlen et al., 2017), many cells died within two days (data not 
shown). Therefore, microglial cell cultures were maintained in the growth medium 
containing serum and L929 cell-conditioned medium (DMEM/FCS/L929), and the 
experiments were conducted in serum-free TIC medium after serum-deprivation of the 
cells. The medium containing TGF-β2, CSF-1/IL-34 and cholesterol (TCC/TIC) is by far 
the minimal medium that keeps the gene expression profile of cultured microglia most 
similar to those in the brain. The gene expression of microglia is always changed in 
culture but restored when the cells receive instructive signaling from the intact CNS again 
(Bohlen et al., 2017). Nevertheless, cell culture models provide the opportunity to study 
specific cellular mechanisms. 
 
Less fusion of phagosomes containing myelin debris with acidified compartments labeled 
by LysoTracker was observed in Myd88-/- than WT microglia, indicating that phagosome 
maturation after the phagocytosis of myelin debris is regulated by MyD88-dependent 
pathways (Figure 6). The microglia cultured in DMEM/FCS/L929 medium had enlarged 
lysosomes labeled by LysoTracker (data not shown), and therefore the cells were 
incubated in serum-free TCC medium overnight before experiment for them to reach the 
baseline condition. Each experiment of WT and Myd88-/- microglia cultures was performed 
on the same day for the comparison between genotypes. The fusion of phagosomes 
containing myelin debris with lysosomes is being validated by electron microscopy (EM). 
 
The phagocytosis of myelin debris by Myd88-/- microglia was also analyzed. Less PKH67-
labeled myelin debris was found in cultured Myd88-/- microglia than WT microglia 30 min 
(Figure 5A and B) or 60 min after the exposure to myelin (Figure 6E and F), and after 2 h 
of myelin treatment (Figure 5C and D). Thus, Myd88-/- microglia might phagocytose less 
myelin debris or the phagocytosis is delayed compared with WT microglia. To test 
whether the internalization of myelin debris was defective, myelin proteins could be 
stained in treated microglia using antibodies with or without permeabilization, which can 
distinguish phagocytosis from the binding of myelin debris (Blander and Medzhitov, 2004). 
 
The regulation of phagocytosis and phagosome maturation is dependent on the 
phagocytic cargo. The defect in phagosome-lysosome fusion for internalized myelin debris 
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is similar to the discovery of impaired phagosome maturation after the phagocytosis of 
bacteria in Myd88-/- macrophages, whereas the maturation of the phagosomes containing 
apoptotic cells was found independent of MyD88 pathways (Blander and Medzhitov, 
2004). To determine whether myelin debris was internalized into the same or separate 
phagosomes containing bacteria or beads, cultured WT and Myd88-/- microglia were 
treated with myelin debris, heat-inactivated E. coli and latex beads altogether and are 
being analyzed by EM. 
 
Furthermore, the degradation of internalized myelin debris by microglia is being analyzed. 
Since phagosome maturation is an essential step for internalized materials to be 
degraded in the lysosome, we hypothesized that myelin debris would be retained in 
Myd88-/- microglia due to impaired phagosome-lysosome fusion. After WT and Myd88-/- 
microglia were treated with myelin debris for 2 h, the amount of myelin in each cell was 
analyzed at various time points. The amount of myelin debris in microglia / macrophages 
will be also analyzed in the lesions of WT and Myd88-/- mice by immunohistochemistry for 
LAMP-2, IBA1 and FluoroMyelin at 14 and 21 DPI. FluoroMyelin™ Fluorescent Myelin 
Stains (Molecular Probes™) label lipids, especially myelin and lipid droplets inside the 
cells (Cantuti-Castelvetri et al., 2018; Monsma and Brown, 2012). If persisted expression 
of LAMP-2 (Mac-3) is observed in microglia / macrophages in the lesions of Myd88-/- mice 
at a late time point, it might suggest stalled phagosome maturation. However, the amount 
of FluoroMyelin stain could be the consequence of both phagocytosis and degradation of 
internalized myelin debris in vivo. If a microglial cell or macrophage containing myelin 
debris dies, another cell would clear the dead cell and the debris released by the dead 
cell. After microglia phagocytose damaged myelin, fast phagosome maturation may be 
required for timely degradation of myelin debris without the chance to present partially 
digested epitopes from myelin as antigenic peptides (Pauwels et al., 2017). The 
accumulation of large amounts of cholesterol in phagosomes has been found to impair 
their fusion with lysosomes in macrophages (Huynh et al., 2008), and the high cholesterol 
content of myelin might render myelin debris challenging for phagosome maturation to 
occur in MyD88-deficient microglia / macrophages. Too much accumulation of myelin 
debris in microglia / macrophages can lead to, for example, the formation of cholesterol 
crystals and damage to lysosomes, causing maladaptive inflammatory response and 
impaired remyelination (Cantuti-Castelvetri et al., 2018). 
 
Since microglia phagocytose myelin debris and detect the damage to myelin, we asked 
whether activated microglia would trigger general tissue repair or specific regenerative 
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process in response to demyelination. When microglia were exposed to the same amount 
of purified myelin debris or non-myelin membrane, they phagocytosed more myelin than 
non-myelin membrane, and the uptake was faster (Figure 4D and E). The amount of 
myelin or non-myelin membrane in microglia was quantified from the fluorescence 
intensity of PKH67 dye, which binds to the lipid regions of cell membrane (Horan et al., 
1990; Wallace et al., 2008). The ratio of the integrated fluorescence intensity of myelin to 
non-myelin membrane in the cells was higher than the ratio of the fluorescence of PKH67-
labeled myelin to non-myelin fraction (Figure 4G). Therefore, microglia indeed 
phagocytosed more myelin than non-myelin fraction, and the observation was not due to 
the artifact of fluorescent labeling. According to the kinetics of the phagocytosis of myelin 
debris, microglia internalized around half of the maximum amount of myelin after 4 h of 
exposure (Figure 4D). After 2 h of treatment with myelin, the vast majority of microglia 
had internalized some myelin debris, and therefore this duration of treatment was applied 
to the clearance assay (Figure 5C). In the assay for phagosome maturation, the uptake of 
myelin debris happened within 15 min of treatment (Figure 6). The fast and rigorous 
phagocytosis of myelin debris allows microglia to readily detect the damage to myelin and 
initiate the responses to demyelination. 
 
 
Microglia activation and secretion during remyelination 
The activation of microglia was analyzed in both cell culture and demyelinated lesions. 
The condition after demyelination was modeled in vitro by treating cultured microglia with 
purified myelin debris. The responses of individual microglia in the same culture was 
heterogeneous in terms of the amount of myelin debris in each cell (Figure 5B and D, 
Figure 6F, Figure 7, Figure 4A and E), the expression of activation markers and 
morphology (Figure S1) and so on. The heterogeneity of microglia activation in vivo 
(Hanisch and Kettenmann, 2007; Ransohoff, 2016) was recapitulated in cell culture. 
 
The transcriptome and proteome of cultured microglia were analyzed in order to identify 
the molecules and pathways involved in the activation and secretion of microglia after the 
exposure to myelin debris. The transcriptome of cultured microglia is being analyzed by 
next-generation sequencing. Most proteins identified in the supernatant of microglia 
culture by mass spectrometry are annotated as secreted proteins in the Uniprot database 
(Figure 8). The proteins that are not annotated as secreted proteins might be shed 
transmembrane proteins, or secreted unconventionally in serum-free medium; they might 
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also come from exosomes or dead cells (communication with Dr. Stephan Müller). The 
proteins that were found in different amounts in both the comparisons “myelin-treated vs. 
control WT microglia” and “myelin-treated Myd88-/- vs. WT microglia” (Figure 9) are listed 
in Appendix 1. Some of these proteins will be briefly discussed here. 
 
The TGF-β superfamily member growth/differentiation factor 15 (GDF-15) was increased 
in the supernatant after WT microglia were exposed to myelin debris but less upregulated 
by Myd88-/- microglia (Appendix 1). GDF-15 has been found to be expressed in glioma 
and to enhance the proliferation of glioma cells (Roth et al., 2010). As GDF-15 has 
cytokine and growth factor activities (Machado et al., 2016; Strelau et al., 2000), it might 
promote the proliferation of OPCs. The Gdf15 gene is primarily expressed in microglia / 
macrophages (782.8742 ± 241.7605 FPKM) in the mouse brain, according to the Brain 
RNA-Seq database (Zhang et al., 2014). However, the causal relationship between GDF-
15 and glioma has to be investigated carefully before considering GDF-15 as a candidate 
molecule for OPC proliferation during remyelination. 
 
The metalloproteinase inhibitor 1 (TIMP-1) was also induced by myelin treatment of WT 
microglia and less upregulated by Myd88-/- microglia (Appendix 1). Apart from inhibiting 
metalloproteinases, TIMP-1 also has growth factor activity and can regulate integrin 
signaling (Uniprot). TIMP-1 has been shown to promote OPC proliferation and 
differentiation and astrocyte proliferation (Moore et al., 2011). TIMP-1-/- mice after 
experimental autoimmune encephalomyelitis (EAE) had increased infiltration of 
lymphocytes, prolonged activation of microglia / macrophages and more severe myelin 
damage (Crocker et al., 2006). The expression of Timp1 is low in endothelial cells (11.399 
± 0.0394 FPKM) and almost undetectable in other mouse brain cell types (Brain RNA-
Seq), but the expression is upregulated during postnatal development (Ulrich et al., 2005) 
and after injury. TIMP-1 expression was observed in activated astrocytes around the 
lesions in models of CNS inflammatory disorders by in situ hybridization (Pagenstecher et 
al., 1998), whereas in another study of EAE, macrophages were identified to be a major 
source of TIMP-1 by FACS and real-time RT-PCR (Toft-Hansen et al., 2004). According to 
the secretome analysis, TIMP-1 might be expressed by microglia in response to myelin 
debris to promote the proliferation of OPCs and astrocytes. 
 
Two proteins involved in phagocytosis-induced inflammation were identified in the 
secretome of cultured microglia. Collectin-12 (CL-12) was found to be increased in the 
supernatant of WT microglia after the exposure to myelin debris, but the amount was 
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lower in the supernatant of Myd88-/- microglia after myelin treatment. Oppositely, less 
annexin A5 (or annexin V) was secreted by WT microglia upon myelin treatment, but more 
annexin A5 accumulated in the supernatant of Myd88-/- microglia after the exposure to 
myelin debris (Appendix 1). Phagocytosis of necrotic or lysed cells usually activates 
inflammation and immune response, contributed in part by members of the collectin family 
(Henson et al., 2001). Soluble CL-12 has been shown to recognize a fungal pathogen and 
activate the alternative complement pathway (Ma et al., 2015). On the other hand, 
phagocytosis of apoptotic cells does not trigger inflammation or immune response. It has 
been suggested that upon the binding of phosphatidylserine (PS) exposed on the outer 
membrane leaflet of apoptotic cells to PS receptor (PSR), PSR signaling generates an 
anti-inflammatory effect. Annexin A5 could block PSR signaling by binding to PS and 
disrupting the interaction between PS and PSR, thereby allowing the generation of pro-
inflammatory molecules (Stach et al., 2000). If the PS exposed on myelin debris were 
recognized by surface receptors of microglia, decreased annexin A5 would allow more 
binding and possibly the expression of anti-inflammatory cytokines by WT microglia later. 
The increased secretion of annexin A5 by Myd88-/- microglia might reflect the 
misregulation of the microglial response to myelin debris. The possibility that CL-12 binds 
to myelin debris and activates complement pathway in microglia or other phagocytes 
might be also interesting to test. 
 
The proteomic data of the cell lysate of cultured microglia were analyzed in terms of 
differential gene expression (Figure 10) and pathway analysis. Apolipoprotein E (APOE) 
was induced in WT microglia after the exposure to myelin debris, which suggests the 
activation of lipid transport by microglia in vitro. The upregulation of APOE was also 
observed in the supernatant of cultured microglia, which did not seem to be affected by 
the lack of MyD88 (data not shown). In WT microglia culture 16 h after 4 h of myelin 
treatment, the so-called “M1” markers were slightly induced, whereas Myd88-/- microglia 
showed higher expression of “M2” markers such as arginase-1 and slightly lower 
expression of “M1” markers (Table 10). Differential gene expression analysis identified 10 
genes that were significant when comparing both myelin-treated vs. control WT microglia 
and myelin-treated Myd88-/- vs. WT microglia (Table 9). Further analysis of the proteome 
of microglial cell lysate was conducted using Ingenuity Pathway Analysis (IPA). 
 
Among the upstream regulators predicted in both comparisons (Figure 9), IFN-γ-
regulated pathways were activated in WT microglia after the exposure to myelin debris, 
but were inhibited in Myd88-/- microglia after myelin treatment compared with WT microglia 
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(Table 11). In WT microglia, myelin debris induced the expression of some proteins that 
function in cholesterol metabolic process or cholesterol transport. The upregulation of the 
sterol O-acyltransferase 1 (Soat1) and the ATP-binding cassette sub-family A member 1 
(Abca1) was predicted to be activated by IFN-γ-regulated pathway(s) directly or indirectly. 
The increase of cathepsin L1 (encoded by the Ctsl gene; the human ortholog cathepsin L2 
is encoded by the CTSV gene), a protease that is important for protein degradation in 
lysosomes, suggests the activation of lysosomal function in WT microglia after the 
exposure to myelin debris (Figure 11A). By comparing the proteome of Myd88-/- and WT 
microglia after myelin treatment, IPA predicted a mechanistic network regulated by the 
inhibition of IFN-γ-regulated pathways (Figure 11C). The NF-κB complex was predicted to 
be inhibited in WT microglia after myelin treatment (bias-corrected z-score -0.231, p-value 
of overlap 3.15E-02), and inhibited more strongly in myelin-treated Myd88-/- microglia 
(Figure 11C). Myelin debris activated the translocation of NF-κB into the nucleus of 
cultured WT microglia, but the effect was less prominent than lipopolysaccharide (LPS), 
as detected by immunocytochemistry for the p65 subunit (24 h treatment in serum-free 
TCC medium; 30 µg/mL myelin; 10 ng/mL LPS (Sigma, L4516); data not shown). The 
predicted inhibition of NF-κB complex might explain the less strong nuclear translocation 
induced by myelin debris than LPS in WT microglia. However, the nuclear translocation of 
NF-κB did not seem to be abolished in Myd88-/- microglia (data not shown). The activation 
of NF-κB and MAP kinases was actually reported in Myd88-/- mice (Kawai et al., 1999), 
although the induction of cytokines and IFN-γ was abrogated (Adachi et al., 1998). In the 
mechanistic network (Figure 11C), the predicted activation or inhibition of signaling 
molecules such as STATs should be validated carefully, because the activity depends on 
phosphorylation and translocation into the nucleus, but mass spectrometry measures the 
amount of peptides/proteins. It has been shown that the signaling of type I IFN receptor 
(IFN-α/β receptor) is not necessary for remyelination (Schmidt et al., 2009). The 
cuprizone-induced demyelinated lesions of IFN-β-knockout mice had more OPCs and 
faster remyelination than WT at an early phase of remyelination but became similar later 
(Trebst et al., 2007). The microglia activation phenotypes in response to myelin debris 
might share some similarities with the “late response microglia” induced by type II IFN, 
which was identified by single-cell RNA-seq during the progression of neurodegeneration 
(Mathys et al., 2017). IFN-γ was not identified in either the supernatant or the lysate of 
cultured microglia (Figure 8); it probably represents a node of gene expression regulated 
by various pathways, or it was expressed or secreted at a minute amount. Whether the 
IFN-γ-induced microglia phenotype is beneficial or harmful for regeneration is not clear. 
The predicted pathways will be analyzed in more details to generate hypotheses that can 




The pathways regulated by peroxisome proliferator-activated receptor α (PPAR-α), PPAR-
δ and PPAR-γ coactivator 1-α (Ppargc1a), which are involved in lipid metabolic processes 
(Moore and Tabas, 2011), were predicted by IPA to be activated in WT microglia after the 
exposure to myelin debris but less activated in Myd88-/- microglia. The transcription factor 
activator protein 1 (AP-1, encoded by the Jun gene), which can be activated by MAP 
kinases downstream of MyD88 signaling, was predicted to be inhibited in myelin-treated 
WT microglia but less inhibited in Myd88-/- microglia (Table 11). IPA did not identify any 
common pathways regulated by IRFs, which could also be downstream of MyD88 
signaling, in both the comparisons of myelin-treated vs. control WT microglia and myelin 
treated Myd88-/- vs. WT microglia. 
 
In order to identify the activation phenotypes of microglia and the secreted molecules that 
are required for remyelination in vivo, we performed three RNA sequencing experiments 
of demyelinated lesions isolated from the spinal cord of WT and Myd88-/- mice. We 
reasoned that microglia / macrophages were the dominant cell types in the lesions at 7 
DPI, and therefore the gene expression profile of microglia / macrophages would 
contribute most to the transcriptome of the lesions. The expression of secreted molecules 
would also be reflected in the transcriptome. However, the analysis of the bulk RNA-seq 
of the lesions did not generate much insight due to the complex cell composition. In the 
first experiment, the spinal cords were sectioned using a vibratome, and the lesions were 
dissected using a blade at 2, 4, 7 and 21 DPI. This dissection method might have included 
variable amount of normal white matter in the samples, and the lesions might contain 
unknown proportions of each cell type at various time points. In the second experiment, 
microglia / macrophages were isolated from the lesions by MACS using anti-CD11b 
MicroBeads. To obtain enough material for RNA-seq, the lesions of two or three mice 
(four injection sites in each mouse) at 7 DPI were pooled in one sample, resulting in a 
small sample size. In the third experiment, the lesions at 7 DPI were isolated accurately 
by laser microdissection. The differential gene expression analysis (Figure 12) and 
pathway analysis identified differences between the lesions of Myd88-/- and WT mice in 
many cellular processes and pathways, including inflammation, signaling, metabolism and 
so on. The transcriptomic data of lesions did not correlate well with the secreted proteins 
(such as Gdf15 and Timp1) identified in the supernatant of cultured microglia by 
proteomics, but further pathway analysis of the transcriptome of lesions might provide 
novel hypotheses about the molecular mechanisms of remyelination in vivo. Due to the 
complex cell composition in lesions, single-cell analysis would be a powerful method for 
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identifying the activation phenotypes of microglia and other cells that are relevant to the 
stage of the disease or regeneration, even though the important subpopulations do not 
dominate in terms of cell number. Nevertheless, bulk RNA-seq of lesions have the 
advantage of intact tissue, because the generation of a single-cell suspension might affect 
gene expression (Espina et al., 2006). 
 
We cannot exclude the possibility of Myd88 expression in cell types other than microglia / 
macrophages after injury in the CNS. However, since microglia predominantly express 
Myd88 in the CNS, impaired maturation of the phagosomes containing myelin debris in 
microglia might be one of the first steps that had defects in the lesions of Myd88-/- mice 
during remyelination. The defects in phagosome maturation could affect the degradation 
of myelin debris and cause the accumulation of myelin debris in microglia. The signaling in 
microglia could also be disrupted by the lack of the adaptor protein MyD88. Consequently, 
microglia may not reach the appropriate activation states for promoting OPC proliferation, 
migration and differentiation, and/or creating an environment supportive for remyelination. 
The proteomic analyses of cultured microglia identified candidate molecules and 
pathways involved in the microglial response to purified myelin debris, but challenges 
remain to find the combination of molecules that is sufficient to promote remyelination. 
Furthermore, demyelinated lesions in a patient are heterogeneous – some lesions are in 
the phase of OPC recruitment, while others might require OPC differentiation (Franklin 
and Ffrench-Constant, 2017). After the molecular mechanisms of remyelination is 
unraveled by science, more effective therapy will still depend on the methods to determine 
which step of remyelination is limited in the patient. 
 
 
Validation of candidate molecules for the effects on OPC response 
The candidate molecules identified in the proteomic and transcriptomic analyses of 
cultured microglia and demyelinated lesions will be tested for their effects on OPC 
responses in tissue culture. The effect on OPC proliferation can be tested in OPC culture, 
using EdU to label proliferating cells (Figure S2). The OPC proliferation assay is being 
optimized in the OPC culture prepared by immunopanning (Watkins et al., 2008) using 
platelet-derived growth factor-AA (PDGF-AA) as a positive control (McKinnon et al., 1990; 
Raff et al., 1988). The effect on oligodendrocyte differentiation and myelination will be 
tested in organotypic hippocampal slice culture (OHSC) using 3,3’,5-triiodo-L-thyronine 





Lack of remyelination in organotypic hippocampal slice culture 
Ex vivo demyelination models were established for studying the mechanisms of 
remyelination and testing candidate molecules. Slice cultures are more accessible for 
experimentation than in vivo models, and the cell types and cellular architecture are better 
preserved than cell culture. Myelination develops in OHSC robustly (Figure 13), and the 
method to deplete and replenish microglia in OHSC provides a valuable tool for studying 
the roles of microglia in response to demyelination and during remyelination (Masuch et 
al., 2016). Lysolecithin-induced demyelination model has been established in organotypic 
cerebellar slice culture (OCSC) (Zhang et al., 2011). However, cerebellar slices become 
very thin and fragile in culture, making OCSC not ideal for the replenishment of 
exogenous microglia. Therefore, demyelination models were established in OHSC. 
 
The injection of lysolecithin into organotypic hippocampal slices induced focal 
demyelination consistently, whereas the injection of PBS vehicle control left the myelin 
sheaths relatively intact. The treatment of OHSC with lysolecithin disrupted myelin only on 
the surface of the slices, but lysolecithin did not penetrate through the thick slices. 
Treatment with higher concentrations of lysolecithin or for extended time caused extensive 
cell death. Therefore, a small amount of lysolecithin was injected into the slices to induce 
focal demyelination. However, remyelination was not observed 7 or 14 days after the 
injection of lysolecithin (Figure 14D and E). We speculated that lysolecithin led to cell 
death where it diffused to in the slices, resulting in insufficient OPCs for remyelination to 
occur. Therefore, an autoimmune demyelination model that selectively targets myelin and 
mature oligodendrocytes was established. Anti-MOG antibody and complement mediated 
demyelination in OHSC significantly (Figure 15A-C), but most axons remained 
unmyelinated 7 days after the treatment with anti-MOG antibody and complement was 
stopped (Figure 15E). The lack of remyelination in these two demyelination models might 
be due to the loss of regenerative capacity of the OPCs in hippocampal slices in culture, 
or regional differences of OPCs in terms of their remyelination capacity. The OPCs in 
organotypic cerebellar slice culture may be able to maintain their regenerative properties 
and perform remyelination (Zhang et al., 2011). If demyelination happens in the 
hippocampus, the progenitor cells might proliferate and migrate from the subventricular 
zone (SVZ) to the demyelinated lesion to perform remyelination. OPCs could be added to 





MOG antibody and complement-mediated demyelination in OHSC 
The treatment of myelinated OHSC with 10 µg/mL anti-MOG Z2 antibody and 5% guinea 
pig complement for 72 h induced demyelination (Figure 15C). The ~51% reduction of 
myelination index by Z2 antibody might be enlarged by increasing the concentration of 
complement without affecting the viability of OHSC. Anti-MOG antibody and complement 
mediated demyelination in the absence of T lymphocytes. Therefore, this model can be 
used to study the mechanisms of autoimmune demyelination and cellular responses to 
myelin damage without the complication of T cell infiltration in vivo. 
 
In the OHSC depleted of microglia using clodronate (Kreutz et al., 2009; Masuch et al., 
2016), anti-MOG Z2 antibody did not induce demyelination effectively compared with the 
isotype control (Figure 15F), which suggests the involvement of microglia in antibody and 
complement-mediated demyelination independent of T cells. Interestingly, Z2 antibody 
and complement did not induce demyelination in OHSC prepared from Myd88-/- mice as 
they did in WT OHSC (Figure 15G). This suggests that the antibody and complement-
mediated phagocytosis of (opsonized) myelin might require MyD88-dependent activation 
of microglia. After the exposure to myelin debris, cultured Myd88-/- microglia expressed 
lower levels of IgG Fc receptor I (high affinity immunoglobulin gamma Fc receptor I; 
encoded by the Fcgr1 gene, an ortholog of the human FCGR1A gene) than WT microglia, 
as analyzed by proteomics and IPA (Figure 11B). The IgG Fc receptor I on the surface of 
microglia might bind to the Fc part of anti-MOG IgG, activating the phagocytosis of 
opsonized myelin. The preliminary results need validation by independent experiments, 
but they suggest a potential role of microglia in autoimmune demyelination by 
phagocytosing opsonized myelin. In contrast, microglia may regulate inflammatory 
response and secrete signals to guide remyelination in the toxin-induced demyelination 
model. Thus, the pathological context and specific activation phenotypes of microglia may 
determine the effector functions of microglia and whether the outcome of microglia 





The MyD88-dependent recruitment of OPCs may be specific to remyelination in the 
adult CNS 
It has been observed that a large number of activated microglia are present in the 
developing forebrain SVZ and reaches maximum in the early postnatal weeks, which 
coincides with the initiation of myelination. The activated microglia might promote 
oligodendrocyte development by producing TNF-α, IL-1β, IL-6 and IFN-γ (Shigemoto-
Mogami et al., 2014). Amoeboid microglia expressing LAMP-2 have been shown to peak 
in the developing white matter at postnatal day (P) 7 (Hagemeyer et al., 2017). Therefore, 
we asked whether the recruitment of OPC for developmental myelination requires MyD88 
signaling in microglia. The number of OPCs in the corpus callosum was similar in WT and 
Myd88-/- mice at P7 (Figure 16), which suggests that the MyD88-dependent regulation of 
OPC number may not be a key mechanism during development. The responses of 
microglia to TLR activation have been shown to reorganize and mature during postnatal 
development (Scheffel et al., 2012), which might explain the reason why MyD88-
dependent recruitment of OPCs is necessary for remyelination in the adult CNS but 
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Activation of cultured microglia / macrophages after the exposure to myelin debris 
The expression of several activation markers by cultured microglia or macrophages was 
checked after myelin treatment. Microglia were isolated by MACS and cultured in 
DMEM/FCS/L929 medium for 2 days, and then treated with myelin for 4 h in serum-free 
TCC medium. Most microglia expressed the activation marker iNOS, for instance (Figure 
S1C). Macrophage culture expressed activation markers such as galectin-3 and MHC 




Figure S1. Cultured microglia and macrophages expressed activation markers after the exposure 
to purified myelin debris. After 24 h of treatment with myelin, macrophages (magenta) expressed 
(A) galectin-3 (green) and (B) MHC class II (green). (C) Microglia (magenta) expressed iNOS 
(green) after 4 h of treatment with myelin. 
 
 
OPC proliferation measured by EdU in tissue culture 
 
Figure S2. Proliferating cells were labeled with 10 µM EdU for 2 days in OHSC. The co-labeling of 
EdU (green) and OLIG2 (magenta) identifies the nucleus of an oligodendrocyte-lineage cell that 




Appendix 1. The proteins detected in the supernatant of microglia culture whose amount was significantly different in the two comparisons myelin_Myd88-/- / 
myelin_WT and myelin_WT / control WT (log2(LFQ ratio) ≤ -0.5 or ≥ 0.5, and p-value < 0.05). 
  
log2 LFQ fold changes t-test p-values 
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Appendix 2. Pathway analysis of the proteomic data of the cell lysate of cultured microglia using the gene ontology enrichment analysis and visualization tool 
(GOrilla). (A) WT microglia after the exposure to myelin compared with control. (B) Myd88-/- microglia compared with WT microglia after the exposure to 
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